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ABSTRACT 
 
The rising rate of insulin resistance and type 2 diabetes in humans over the past two decades have 
been linked to increasing rates of obesity, aging and urbanisation. A similar pattern is occurring in 
domestic animals, specifically cats and dogs. Skeletal muscle is a vital organ in the regulation of 
blood glucose. Its composition in terms of muscle fibre type, metabolism and contractility can differ 
substantially between species, but is poorly studied in the domestic dog, in particular the various 
breeds. It was hypothesised that insulin resistance and type 2 diabetes may be associated with muscle 
fibre type, in particular, muscle with a low type I fibre content being a predisposing factor. Therefore, 
the aims of this study were to investigate the skeletal muscle fibre composition and metabolic profile 
in the Triceps brachii (TB) and Vastus lateralis (VL) of 16 breeds of domestic dogs (Canis lupus 
familiaris). A secondary aim was to correlate the skeletal muscle composition with breeds reported 
as having a high incidence of diabetes. Skeletal muscle samples were collected post mortem from the 
TB and VL of 38 dogs from different breeds, age and sex, and analysed for fibre type composition, 
fibre size, oxidative and glycolytic metabolic capacity (citrate synthase (CS), 3-hydroxyacetyl co A 
dehydrogenase (3-HAD), creatine kinase (CK) and lactate dehydrogenase (LDH) enzyme activities). 
There was no significant difference between the TB and VL in any of the measurements. Type IIA 
was the predominant fibre type for both muscle groups (TB: 43%; VL: 44%) followed by type I (TB: 
33%; VL: 38%) and type IIX (TB: 24%; VL: 18%). The cross sectional area (CSA) of the fibres were 
all smaller compared to humans and other wild animals. Surprisingly, there was no difference in the 
CSA between the fibres types and muscle groups: Type I: TB: 1740 µm2; VL: 1712 µm2, Type IIA: 
TB: 1690 µm2; VL: 1720 µm2, Type IIX TB: 1726 µm2; VL: 1791 µm2). Metabolically, the muscle 
of the dog displayed a high oxidative capacity with high activities (all activities in µmol/min/g 
protein) for CS (TB: 61; VL: 49) and 3-HAD (TB: 53; VL: 46). Lower CK (TB: 6115; VL: 6279) 
and higher LDH (TB: 1550; VL: 1478) activities than humans indicated a lower and higher flux 
through the high energy phosphate and glycolytic pathway, respectively. These results indicate that 
the dog has a predominance of type IIA fibres along with a higher oxidative capacity. There appears 
to be no pattern in fibre type profile that could be associated with a predisposition of a specific breed 
to insulin resistance and diabetes, although many of the breeds with a known risk did not form part 
of the study sample. This is the first study to characterise the skeletal muscle composition of a large 
population of dogs (16 breeds), but the association of breed to diabetes was not found. Future studies 
should include younger and more animals, as well as a diabetic population of dogs.  
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CHAPTER ONE 
1. LITERATURE REVIEW 
1.1. What is the problem - an overview of the diabetes epidemic in humans and animals 
The rising rates of obesity, along with aging and urbanization have been linked to the increasing rates 
of  diabetes in the human population (Wagner and Brath, 2012). According to the World Health 
Organisation (2016a) , the prevalence of diabetes in adults have increased from 4.7% in 1980 to 8.5% 
in 2014. In 2015, there were 422 million people living with diabetes while 1.5 and 2.2 million deaths 
in 2012 were directly attributed to diabetes and high blood glucose, respectively. The International 
Diabetes Federation Atlas (IDF, 2017) predicted that the number of people living with diabetes 
globally will increase from 424.9 million in 2017 to a staggering 628.6 million in 2045.  
A similar pattern was observed in the domestic animal populations, specifically in relation to the 
increasing rates of obesity (Osto and Lutz, 2015) . In an Australian study investigating obesity in 
2661 dogs, 34% of the dogs were overweight and 8% were obese as determined by veterinarians 
using the Hill’s weight guide chart for dogs (McGreevy et al., 2005). In a 2015 survey looking at pet 
obesity in the United States, an estimated 20% of dogs and 28% of cats were obese (APOP, 2015). 
Both cats and dogs have varying rates of diabetes incidence and prevalence as well as risk factors for 
the disease, with diabetes being a relatively common endocrine disease in cats with a prevalence of 1 
in 230 in a UK study (McCann et al., 2007). Diabetes in dogs is not as prevalent. From a cohort of 
180 000 dogs investigated in Sweden, only 1 dog was diagnosed with diabetes for every 770 dogs, 
with different incident rates for different breeds (Fall et al., 2007).  
Although the pancreas is responsible for insulin production and secretion in response to high blood 
glucose, it is the target of this hormone that is essential in the uptake of excess glucose. Skeletal 
muscle is a vital organ in the regulation of glucose in the body. Importantly, the slow twitch oxidative 
type I fibres have been attributed to higher levels of insulin sensitivity as opposed to the fast twitch 
type II fibres (Duan et al., 2017, Lefaucheur, 2010). Very few studies (with contrasting results) have 
investigated the fibre type and metabolic properties of skeletal muscle from various domestic dog 
breeds. Therefore, knowledge of these muscle characteristics would aid in our understanding of the 
onset of diabetes in dogs and humans.  
1.2.  Diabetes in humans 
Diabetes Mellitus (or simply diabetes) is a non-communicable disease characterized by 
hyperglycemia and results from defects in insulin secretion or insulin sensitivity of target tissues, 
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such as skeletal muscle (Frayn, 2009, Gilor et al., 2016). There are two major forms of diabetes. Type 
1 diabetes (T1D) is a condition that results in absolute insulin deficiency through the destruction of 
insulin secreting pancreatic β-cells (Daneman, 2006). This usually occurs through cell-mediated 
autoimmune attack on the β-cells. However, there is a form of T1D in which destruction of β-cells 
are not due to autoimmune attack, is less frequent, has no known cause and occurs primarily in people 
of African or Asian ancestry (Abiru et al., 2002, Daneman, 2006).   
Type 2 Diabetes (T2D) is characterised by defects in insulin secretion due to β-cell dysfunction, as 
well as the concomitant presence of insulin resistance in tissue (Frayn, 2009, Stumvoll et al., 2005). 
Insulin resistance is the inability of insulin, at normal physiological concentrations, to exert its effect 
on insulin-sensitive tissue, such as skeletal muscle and liver (Frayn, 2009). The body compensates by 
increasing pancreatic β-cell function, resulting in increased insulin secretion. Over time, blood 
glucose concentration gradually increases as the pancreas fails to maintain the required increased 
secretion of insulin. Ultimately, glucose toxicity may lead to β-cell dysfunction (Stumvoll et al., 
2003). Additionally, insulin resistance may progress to T2D if certain environmental and genetic risk 
factors, such as obesity, are present (American Diabetes, 2010, Stumvoll et al., 2005).      
In humans, diabetes is defined as a fasting plasma glucose concentration above 7 mmol/L or a post-
prandial concentration above 11.1 mmol/L, two hours after oral glucose administration (American 
Diabetes, 2010). Glycated haemoglobin (HbA1c) is a measure of average glucose concentrations over 
a period of three months and therefore provides a better representation of long term glucose 
concentrations (Frayn, 2009). An HbA1c above 6.5% is indicative of diabetes (American Diabetes, 
2010).  
1.3. Type 2 Diabetes  
T2D is primarily a lifestyle disease characterised by high blood glucose concentrations and therefore 
it is important to understand the mechanisms of glucose regulation in the body. Insulin is a peptide 
hormone secreted from the β-cells of the pancreas in response to hyperglycemia. Hyperglycemia 
occurs after the ingestion of carbohydrates, which are then broken down into the various 
monosaccharides, predominantly glucose and fructose. Insulin promotes normal blood glucose 
concentration (between 3.9 and 5.5 mM) through cellular glucose uptake as well as by regulating 
carbohydrate, lipid and protein metabolism (Wilcox, 2005). Incidentally, glucagon secreted from the 
α-cells of the pancreas has the opposite effect, increasing blood glucose concentrations in response 
to hypoglycaemia. 
Insulin mediates its action by binding to the extracellular component of insulin receptors, in response 
to glucose, which subsequently triggers a cascade of signalling pathways (Wilcox, 2005). This 
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includes the phosphorylation of the tyrosine residues on intracellular substrate proteins called insulin 
response substrate (IRS). There are four forms of IRS, with IRS-1 predominantly found in skeletal 
muscle. Phosphatidylinositol-3 kinase (PI3K) is activated by the phosphorylation of IRS-1. PI3K, in 
turn, promotes the translocation of glucose transporter 4 proteins (GLUT4) to the cell membrane via 
the phosphorylation of other proteins (such as Akt and PKC). Of these, GLUT4 is the major 
transporter protein in adipose tissue and skeletal muscle. The translocation of GLUT4 vesicles to the 
plasma membrane allows the uptake of glucose into cells. Importantly, skeletal muscle is the major 
tissue for glucose uptake, accounting for 60-70% of whole body insulin-mediated uptake (Smith, 
2002). In addition, the liver and adipose tissue also contribute as sites of glucose uptake and storage.     
Exercise, through muscle contraction, results in increased skeletal muscle glucose uptake (and can 
increase 16 fold). This occurs through various signalling pathways such as the increase in AMP, nitric 
oxide and calcium, which potentially converge at protein kinase C (PKC) phosphorylation (Ojuka 
and Goyaram, 2014). This leads to the translocation of GLUT4 to the muscle cell membrane and, 
therefore, the uptake of glucose into the cells. Once exercise stops, GLUT4 is returned to the cytosol 
through a process of endocytosis. Because of these two independent pathways (i.e. exercise and 
insulin secretion), frequent physical exercise is beneficial and prescribed for individuals with 
impaired glucose tolerance and insulin resistance (Dela et al., 2014, Ojuka and Goyaram, 2014). Low 
carbohydrate diets have also been shown to be effective in the management of diabetes and insulin 
resistance (Feinman et al., 2015). T2D is characterised by high blood glucose and, therefore, 
restriction of carbohydrate ingestion would lead to reduction in postprandial and overall glucose 
concentration and HbA1c (Accurso et al., 2008, Feinman et al., 2015).  Ultimately, this would reduce 
the amount of insulin secreted by the pancreas in response to hyperglycemia and put less 
compensatory strain on the insulin-dependent signalling pathways. 
As mentioned previously, insulin resistance is an inability of tissue (such as skeletal muscle and the 
liver) to respond normally to insulin and thus precedes T2D. In insulin resistant individuals, insulin 
signalling through IRS-1, PI3K and Akt is decreased, which ultimately leads to decreased GLUT4 
translocation to the cell membrane and thus reduced insulin-mediated glucose uptake (DeFronzo and 
Tripathy, 2009). Consequently, the skeletal muscle protein content of IRS-1 and GLUT4 can act as 
markers of insulin sensitive tissue.  
1.4. The consequences and risk factors of diabetes in humans   
Diabetes increases the risk of cardiovascular morbidity and mortality (Resnick et al., 2001). There 
are both micro- and macrovascular complications associated with diabetes (Beckman et al., 2002). 
Some of the microvascular complications include nephropathy and retinopathy, while macrovascular 
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complications include diseases of the coronary arteries, peripheral arteries and carotid vessels. 
Importantly, hypertension, coronary artery disease and cerebrovascular disease occur more frequently 
in people with T2D compared to matched controls (Beckman et al., 2002). Visual impairment and 
blindness caused by diabetes occurs often in developed countries (Resnikoff et al., 2004).  
There are many health implications of diabetes, which places a heavy economic burden on both 
patients and society. People with diabetes may require three times the health care resources compared 
to non-diabetics and diabetes care could make up 15% of a national healthcare budget (Wagner and 
Brath, 2012, Zhang et al., 2010). In 2017, an estimated $726 billion was spent globally on diabetes-
related healthcare for adults between the ages of 20 and 79 years (IDF, 2017). This diabetic epidemic 
has far-reaching consequences.  
The rising rates of obesity, along with aging and urbanization have been linked to the diabetes 
epidemic with nearly 90% of T2D cases associated with obesity (Wagner and Brath, 2012). Obesity 
is defined as a body mass index of higher than 30kg/m2 and in 2014, more than 600 million (±8.5% 
of the total world population) adults worldwide were obese (WHO, 2016b). Genetic and 
environmental factors are important determinants of insulin resistance and β-cell dysfunction (Kahn 
et al., 2014). According to Kahn et al. (2014), the interaction between genes that affect adiposity and 
environmental factors (such as low energy expenditure, high caloric intake, nutrient composition, 
etc.) leads to obesity and associated insulin resistance. However, when genes for β-cell dysfunction 
are also present, the risk is greater that T2D will develop.  In a study by Shai et al. (2006), it was 
found that the relative risk of diabetes is different between different ethnic groups with Asian, 
Hispanic and Black populations having a greater risk than white populations. Thus, different 
ethnicities are also a potential risk factor, but needs to be further investigated.  
1.5. Animal models of diabetes    
Historically, dogs have played a key role in our understanding of the pathophysiology and treatment 
of diabetes. In 1890, while studying the role of the pancreas in digestion, Von Mering found that the 
removal of the pancreas from a dog led to the presence of glucose in the urine (Mering and 
Minkowski, 1890). He concluded that some “factor” released from the pancreas (later called insulin) 
allows the body to utilise glucose. Later in the 1920's, a diabetic crossbreed by the name of  Marjorie, 
was the first recipient of insulin treatment, which was the platform for future human treatments 
(Banting et al., 1922). Dogs are believed to have a form of diabetes similar to T1D, as dogs are 
dependent on insulin therapy to treat hyperglycemia (Kennedy et al., 2006, Nelson and Reusch, 2014). 
Secondly, the presence of autoantibodies against islet cells, insulin, pro-insulin, GAD5 and IA2 in 
dogs may indicate an immune-mediated component. Lastly, T1D in humans is strongly associated 
 13 
with major histocompatibility complex class II polymorphisms, and associations have also been 
found between the canine dog leukocyte antigen and diabetes (Kennedy et al., 2006).     
Cats are believed to develop a form of diabetes similar to human T2D, as they develop pancreatic 
islet amyloid deposits, which are a marker of T2D in humans (Hoenig, 2014, Hull et al., 2004). These 
depositions have yet to be discovered in dogs. In a study by Hoenig et al. (2000), they found that 
antibodies against β-cells and insulin were absent in healthy and diabetic cats. Therefore, cats do not 
experience autoimmune destruction, which is a characteristic of T1D.   
Rats and mice are commonly used as animal models for T1D and T2D. In T2D rodent models, the 
characteristics of insulin resistance and β-cell failure are modelled (King, 2012). These include non-
obese models such as hIAPP transgenic mice that express the human islet amyloid polypeptide 
(IAPP). Rodents do not naturally produce amyloid, which is an important aspect of T2D in humans 
(Matveyenko and Butler, 2006). However, there are many more rodent obese T2D models, which 
include monogenic models such as leptin deficient mice (Lepob/ob mice) or polygenic models - the 
latter providing a better representation of the disease (King, 2012). Polygenic models include New 
Zealand obese (NZO) mice that are selectively bred to be leptin resistant and hyperinsulinemic, and 
the OLETF rat that is derived from a spontaneously diabetic rat – these rats have mild obesity and 
late onset hyperglycaemia.  
There are many other rodent models for diabetes (transgenic or diet induced) as well as other non-
rodent models to go along with the above mentioned cat and dog models (King, 2012, Osto and Lutz, 
2015). Spontaneous T1D is relatively rare and unpredictable in large animal or non-rodent models. 
As a result, insulin resistance is induced through the surgical removal of the pancreas or the 
destruction of the pancreatic β-cells in these larger animal models (Osto and Lutz, 2015). T2D has 
been reported in several old world non-human primates which include macaque species, African 
green monkeys and baboons (Wagner et al., 2006). They develop similar clinical features and share 
similar risk factors (including obesity) as those observed in humans. Pigs have also been used as a 
model for T2D because of their phenotypic similarities to humans including cardiovascular anatomy 
and function, metabolism, lipoprotein profile, size, obesity tendency and omnivorous diets (Bellinger 
et al., 2006). Pig strains, such as the Yucatan minipig and Ossabaw pigs, have been developed to 
study mechanisms that lead to the development of diabetic complications (Bellinger et al., 2006).  
Although rodent disease models are frequently used to study diabetes, the extrapolation of data 
obtained from these models to humans is relatively poor, primarily due to differences in 
environmental and physiological factors that promote obesity (Osto and Lutz, 2015). For example, 
human diets are more complex than the formulated rodent diets. Different rodent strains may also 
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lead to variability in metabolism (Lai et al., 2014). Rodents are also herbivorous. Due to the lack in 
understanding, there is a need to study alternative models such as dogs and cats, in which obesity 
occurs spontaneously, in order to broaden our knowledge of disease mechanisms. According to Osto 
and Lutz (2015), dogs and cats are good comparative models for human obesity and diabetes, because 
the clinical signs and genetic background of obesity, in terms of it being a polygenic disease with 
different genetic variations, are similar. They also share the same environment as humans, including 
the abundance of food, which may predispose them to similar environmental-based pathophysiology 
(Osto and Lutz, 2015).  
It has already been proposed that the risk of acquiring T2D is different between the various human 
population groups (i.e. ethnicity) (Shai et al., 2006). The same has been observed for dogs, where the 
incidence of diabetes is higher in certain breeds (Fall et al., 2007). Therefore, studying obesity and 
T2D in cats and dogs can serve to (i) elucidate the mechanisms associated with acquiring T2D in 
these species and (ii) to gain a better understanding of the differences between different breeds, which 
may assist in elucidating the ethnic and, hence, genetic differences in humans. For the purpose of this 
thesis, only dogs will be discussed.  
1.6. Diabetes in dogs (Canis lupus familiaris)     
The diagnosis of diabetes in dogs is based on the presence of certain clinical signs and persistent 
hyperglycemia and glycosuria (Nelson and Reusch, 2014). The typical range of plasma glucose 
concentrations for diagnosis of diabetes is 180 - 220 mg/dL in dogs (Nelson and Reusch, 2014), which 
is equivalent to 10 - 12.2 mmol/L. 
In a Swedish study that evaluated 180 000 insured dogs, 1 in every 770  dogs was diagnosed as being 
diabetic, but it appears the incident rates varied for the different breeds (Fall et al., 2007). The 
incidence was 1.33% in an Italian cohort of 186 dogs (Fracassi et al., 2004). There seems to be a 
disparity between European and American studies around which breeds are more predisposed to 
diabetes (Fall et al., 2007, Hoenig, 2014). It appears that Samoyeds, Swedish elkhound and lapphund, 
Fox terriers, Australian terriers, miniature and standard schnauzers, pugs and poodles are at a higher 
risk while American pitbull terriers, cocker spaniels, collies, golden retrievers, German shepherds 
and boxers have a lower risk for developing diabetes. Neutered, females and dogs with previous 
hyperadrenocorticism were also found to be at greater risk (Fall et al., 2007). Obesity has rarely been 
identified as a risk factor and there is presently no recognised association between obesity and 
diabetes in dogs (Rand et al., 2004).       
Catchpole et al. (2008) proposed a diabetic classification system for dogs, independent of the human 
classification system, which focuses on the underlying causes of hyperglycemia. Primary insulin 
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deficiency diabetes (IDD) results from a lack of insulin production by the pancreas and is 
characterised by the progressive loss of β-cells. Primary insulin resistance diabetes (IRD) is a relative 
insulin deficiency that results from inadequate insulin function in insulin-sensitive tissues. IDD is the 
most common, with IRD usually progressing to IDD. Diabetes typically affects dogs between the 
ages of 5 to 12 years old (Davison et al., 2005) which is in contrast to human T1D, which commonly 
develop in childhood with a lower incidence in adulthood (Daneman, 2006). For convenience in this 
thesis, diabetes in dogs will either be referred to as diabetes or T2D.        
1.7. Current diet of domestic dogs  
1.7.1. Ancestral Diet of the wolf Canis lupus 
In order to understand the current diet of domestic dogs, it is important to investigate the origins of 
these animals and the food preference of their ancestors. The dog (Canis lupus familiaris) belongs to 
the order Carnivora in which most animals rely on meat as their primary source of nutrition.  
Dogs are believed to be the first species of animal to have been domesticated, but the exact details of 
this process are still unknown (Vilà and Leonard, 2001). Dogs possibly diverged from their ancestral 
species, the wolf Canis lupus, between 14 000 and 100 000 years ago. The ancestral wolf consumed 
a predominately meat diet although the dentition and habitats of the modern wolf are similar to 
jackals, and as such, more indicative of an omnivorous diet (Bradshaw, 2006). According to 
Bradshaw (2006), due to the long history of domestication and the wide diversity within the domestic 
dog species, it is challenging to generalise the feeding behaviour of these animals. 
1.7.2. Modern Diet of the domestic dog Canis lupis familiaris 
In a comprehensive study by Hewson-Hughes et al. (2013) on domestic adult dogs, the preference of 
dry and wet diets with varying protein, fat and carbohydrate composition was evaluated in different 
breeds. All these diets adhered to the minimum requirement of macronutrients, vitamins and minerals 
as stated in the US National Research Council guidelines (NRC., 2006). The study included five 
breeds of domestic dogs (papillon, miniature schnauzer, cocker spaniel, Labrador retriever and St 
Barnard). Interestingly, the target macronutrient composition was consistent between the breeds with 
30%, 63% and 7% of the energy provided by protein, fat and carbohydrates, respectively. The high 
proportion of protein and fats may be associated with the hunting pattern of the ancestral wolf, which 
hunted in groups and therefore could kill larger prey with more protein and fat as opposed to the lone 
hunting style of the ancestral cat (Prothero, 1995). Another interesting finding by Hewson-Hughes et 
al. (2013) was the tendency of all five breeds to over-eat with 16 of the total 51 dogs being removed 
from the study as a result of reaching their maximum weight gain amount. Therefore, it is easy to 
understand the tendency of domestic dogs to become overweight. Wolves, for example, averaging 
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approximately 55 kg, can consume approximately 10 kg of meat in a single kill, amounting to 18% 
of their own body weight. Thus, the urge for dogs to overfeed may originate from its predecessor 
(Mech and Boitani, 2010).   
Because of domestication, many dogs (as well as other domestic animals) are reliant on their owners 
for care and feeding. Therefore, the animal owner largely decides on the choice of diet for their pet. 
There are a wide variety of commercially available diets that owners could choose from with varying 
macronutrient content (protein, fat and carbohydrate). These diets should all adhere to a national 
regulatory body such as the National Research Council in the United States (NRC., 2006, Zicker, 
2008). Generally, pet food is divided into three forms – dry, semi moist and moist or wet (Zicker, 
2008). Dry food is usually the most convenient to store and to feed pets. It has a water content of less 
than 11% and a higher carbohydrate content than wet food, where cereals, legumes and other plant 
material form the major sources of the carbohydrate component (Hewson-Hughes et al., 2013, NRC., 
2006, Zicker, 2008). Moist or wet foods are typically canned, have a higher water content of between 
60 to 87%, and higher quantities of meat or protein than dry foods (Zicker, 2008). Semi-moist foods 
make up a smaller portion of the pet food market with a water content of 25 to 35% and a relatively 
high sugar content, which makes it highly palatable for dogs (Crane et al., 2010, Zicker, 2008).  
Along with different forms of pet food, there are also a plethora of different brands that owners can 
select from. Examples of such brands include Whiskers and Catmor for cats, and Bobtail and Husky 
for dogs. Hill’s manufactures food for both cats and dogs, with a variety of different diets targeting 
healthy animals or animals with specific diseases or conditions (www.hillspet.co.za). Diet trends are 
a common occurrence in human nutrition, but are also evident in animal diets. For example, the 
emergence of the natural pet food industry and a raw food diet has since seen the light in developed 
countries (Buff et al., 2014, Schlesinger and Joffe, 2011).  
As a result of domestication, the diet is largely driven by the owners of cats and dogs. Although this 
thesis will not be focusing on diet or dietary interventions, future research should focus on its effects, 
especially with regards to skeletal muscle composition and diabetes.             
1.8. The role of skeletal muscle  
1.8.1. Overview and different fibre types 
Skeletal muscle is a heterogeneous tissue consisting of a variety of muscle fibre types. A motor unit 
is defined as a number of muscle fibres innervated by a single neuron that, on activation, will stimulate 
all these fibres to contract at once (Schiaffino and Reggiani, 2011). Thus, motor units are recruited 
by the nervous system in order to fulfil a specific task - the more force required, the more motor units 
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activated. Thus, a direct relationship exists between exercise intensity and motor unit recruitment. 
The heterogeneity of muscle fibres allows skeletal muscle to perform a wide range of tasks, from 
maintaining body posture to locomotion (Schiaffino and Reggiani, 2011). Each muscle fibre consists 
of thousands of myofibrils, which in turn contains millions of myofilaments (Frontera and Ochala, 
2015). The orderly arrangement of myofilaments forms sarcomeres, which are the smallest contractile 
unit of skeletal muscle. Actin and myosin are the two most abundant myofilament proteins.  
Fibre types differ according to their structural, molecular, metabolic and contractile properties and 
these properties result in a variety of functional characteristics (Acevedo and Rivero, 2006). The 
components of skeletal muscle that brings about movement include the contractile proteins and 
metabolism, the latter system being responsible for providing adenosine triphosphate (ATP) to the 
contractile apparatus. The contractile properties of an individual muscle fibre are dependent on the 
myosin heavy chain (MHC) isoform that it expresses. There are three main MHC isoforms expressed 
in adult mammalian skeletal muscle, namely MHC I, IIA and IIX, giving rise to type I, type IIA and 
type IIX fibres, respectively (Bottinelli, 2001, Kohn et al., 2011). 
Type I fibres have slow contraction speeds and rely on oxidative metabolism to supply the required 
ATP. The rate of ATP supply is sufficient to supply energy when the muscle is working at lower 
intensities over prolonged periods of time and allows these fibres to be highly resistant to fatigue. 
Type I fibres also have a dense capillary supply, small cross sectional area, high myoglobin 
concentration, low glycogen but abundant triglyceride stores (Lefaucheur, 2010, Kohn et al., 2011). 
They also have high numbers of mitochondria and GLUT4 content compared to type IIA and IIX 
fibres. Another property of this fibre type important to glucose homeostasis is that they appear to be 
more sensitive to insulin than the other fibre types.  
Type IIX fibres display the opposite characteristics to type I fibres. Glycolytic metabolism is the main 
source of energy with higher glycogen content, low triglyceride and myoglobin concentrations, low 
capillary supply and large cross sectional areas (Kohn et al., 2011, Lefaucheur, 2010). These fibres 
have powerful and rapid contractions, but fatigue easily. They have low mitochondrial and GLUT4 
content and, therefore, lower insulin sensitivity (Duan et al., 2017, Lefaucheur, 2010, Kohn et al., 
2011).     
Finally, type IIA fibres exhibit a mixture of type I and type IIX characteristics. Type IIB fibres have 
extremely fast contraction speeds and are mostly found in the muscles of smaller animals (e.g. 
rodents), and limited to specialised muscles in humans, such as the eye (Toniolo et al., 2007). More 
importantly, the relative proportion of any fibre type varies according to species, anatomical site and 
function (Schiaffino and Reggiani, 2011). Muscle fibres also exhibit plasticity, in terms of 
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composition, so they are able to change according to different physiological needs (Schiaffino and 
Reggiani, 2011).  
An important characteristic of the muscle fibres that may be relevant to T2D is that the different types 
of fibres have varying degrees of insulin sensitivity and GLUT4 content (Daugaard and Richter, 
2004). These are important characteristics, because skeletal muscles are the major site of glucose 
uptake. Indeed, Duan et al. (2017) proposed that targeting the reprogramming of muscle fibres to type 
I could help in the treatment of obesity and T2D. Therefore, it is important to study skeletal muscle 
fibre composition in relation to this disease.  
1.8.2. Overview of metabolic pathways 
The different muscle fibres types have varying oxidative and glycolytic capabilities (Figure 1). In 
order for muscle to perform its various functions, it relies on energy in the form of ATP. Only small 
quantities of ATP are stored, and is replenished via other fuel sources, which include phosphocreatine, 
blood glucose, glycogen and fat. All these fuels are metabolised to generate ATP via different 
metabolic pathways (Hocquette et al., 1998). Type I fibres are oxidative and, because of their high 
myoglobin content and capillary density, make use of substrates from blood such as blood glucose, 
free fatty acids and O2 to yield energy (Frayn, 2009, Frontera and Ochala, 2015). In contrast, type IIX 
fibres have a much greater ATP consumption rate compared to type I, thus requiring ATP at a greater 
turnover rate. They rely on anaerobic glycolysis and make use of glucose-6-phosphate produced from 
glycogen breakdown within the muscle. In humans, most muscle groups comprise of type I, IIA and 
IIX fibres in varying proportions depending on the muscle group, training status and genetics of the 
individual (Frayn, 2009).        
Following muscle contraction, ATP is immediately replenished by intramuscular pools of 
phosphocreatine. Creatine kinase (CK) facilitates the conversion of phosphocreatine to creatine in the 
cytoplasm of the muscle, producing ATP from adenosine diphosphate (ADP) (Frayn, 2009, 
Wallimann, 1994). CK has many isoforms within skeletal muscle and cardiac muscle - all of which 
are involved in ATP production in the cell (Wallimann, 1994). The metabolism of one 
phosphocreatine molecule produces one molecule of ATP and, thus, is a very limited source of ATP 
replenishment. Therefore, muscle is reliant on other sources to obtain more long term energy.  
Blood glucose is brought into the cell through GLUT4 transporters. This action is mediated by insulin 
(after a meal) or muscle contraction (during exercise) (Wilcox, 2005). As in the liver, the glucose is 
either stored as glycogen or metabolised to pyruvate via the glycolytic pathway. Glucose-6-phosphate 
is produced from glycogen by phophorylase and phosphoglucomutase, whereas blood glucose 
imported via the GLUT4 is phosphorylated to glucose-6-phosphate by hexokinase. There are many  
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different enzymes involved in glycolysis that ultimately produces two ATPs for every glucose 
molecule. Phosphofructokinase (PFK) is considered the pacemaker enzyme in glycolysis and as a 
result, plays an important regulatory role (Sola-Penna et al., 2010). PFK catalyses the phosphorylation 
of fructose-6-phosphate to fructose-1,6-bisphosphate and has three isoforms with only one, PFK-M, 
being expressed in skeletal muscle (Sola-Penna et al., 2010). Under anaerobic conditions, pyruvate is 
reduced to lactate via the lactate dehydrogenase (LDH) enzyme. Under aerobic conditions, pyruvate 
is converted into acetyl coenzyme A (acetyl CoA), which then enters the Kreb’s cycle (or citric acid 
cycle) in the mitochondria.  
The citric acid cycle is the most important pathway for energy production in the body and is the 
primary pathway for the oxidation of carbohydrates, proteins and lipids (Akram, 2014). Through β-
oxidation, which consists of many steps and enzymes, fatty acids are converted to acetyl CoA and 
can therefore produce energy in the citric acid cycle (Houten et al., 2016). A marker of the flux 
capacity through this pathway is 3-hydroxyacyl-CoA dehydrogenase (3HAD), an enzyme involved 
in the later stages of β-oxidation (Houten et al., 2016).  
Citrate synthase (CS) catalyses the joining of oxaloacetate with acetyl CoA to produce citrate, which 
is the initial step in the citric acid cycle (Akram, 2014). One ATP, one FADH2 and three NADH 
molecules are produced for each cycle. The FADH2 and NADH molecules then become oxidized 
transferring their electrons to the electron transport chain in the inner membrane of the mitochondria. 
As a result, 36 or 38 ATPs are produced from one exogenous or glycogen-derived glucose 
respectively, through oxidative phosphorylation. Depending on the length of the fatty acid chain, fatty 
acids can produce in excess of 100 ATPs after oxidative phosphorylation (Hocquette et al., 1998). 
However, the rate of fat metabolism is much slower than glucose and glycogen metabolism.       
As described earlier, type I fibres are more reliant on oxidative metabolism, while type II fibres are 
more reliant on glycolytic metabolism to produce ATP. It is for this reason that type I fibres have a 
higher oxidative capacity while type II fibres have a higher glycolytic capacity – with type IIX having 
a higher glycolytic capacity than type IIA fibres (Schiaffino and Reggiani, 2011). Exercise training 
also plays a role in skeletal muscle fibre type distribution and metabolism. Endurance trained athletes 
tend to have a predominance of type I fibres and higher oxidative capacity compared to power/sprint 
athletes who tend to have a predominance of type II fibres and a higher glycolytic capacity (Kohn et 
al., 2007b, Schiaffino and Reggiani, 2011, Tesch et al., 1989). 
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Figure 1. Schematic diagram of the skeletal muscle metabolic pathways that were investigated in this study. 
The yellow circles represent the enzymes used as flux markers of the respective pathways. HK, Hexokinase; 
PHOS, Phosphorylase; PFK, Phosphofructokinase; 3HAD, 3-hydroxyacyl-CoA dehydrogenase; CS, Citrate 
Synthase. 
1.9. The skeletal muscle of dogs  
Over the past 50 years, only seven studies have been published that have investigated the muscle 
composition and metabolic characteristics of dogs. In an early study by Gunn (1978), the 
histochemical properties of trained and untrained greyhounds were investigated. The technique that 
utilises the stability of the myosin ATPase enzyme at alkaline or acidic pH was used to differentiate 
between type I and II fibres. As there were no antibodies against the MHC isoforms at the time, this 
was the preferred technique used in many studies (Guy and Snow, 1981, Latorre et al., 1993, Snow 
et al., 1982). For type I fibres, the mATPase is unstable at a pH lower than 3.9 and greater than 10.4 
while type IIA and IIX fibres can be differentiated at pH 4.6 where IIA fibres are unstable (Brooke 
and Kaiser, 1970). In the study by Gunn (1978), they separated type I and II fibres at pH 9.4 -  fibres 
that have high mATPase activity (darker stains) are indicative of type II fibres and fibres with low 
mATPase activity (lighter stains) are indicative of type I fibres. There was no difference in type I 
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fibre composition between trained and untrained greyhounds in the semitendinosus muscle. 
Compared to other breeds, greyhounds (n=21) had 3% type I fibres compared to collies (n=5) with 
23% (Gunn, 1978). This finding clearly illustrates a breed effect and that overall, dogs have a higher 
proportion of type II fibres compared to horses and humans (Kohn et al., 2011). However, a limitation 
of the comparative dog study of 1978 was that the researchers could not distinguish between type 
IIA, IIX and IIB fibres. In a similar study by Guy and Snow (1981) the fibre type of greyhounds 
(n=6), foxhounds (n=4) and crossbreeds (n=5) in different muscle groups were compared. Although 
this study consisted of a smaller sample size, their findings were similar. The average type II fibres 
in the Vastus lateralis and Triceps brachii were 97% and 94% for greyhounds, 81% and 65% for 
foxhounds, 61% and 77% for crossbreeds, respectively. The results show that along with various 
breeds, different muscle groups have varying proportions of type II fibres, as have been shown in rats 
(Delp and Duan, 1996).           
Due to the difficulty in identifying the sub classes of type II fibres, there have been varying reports 
for the presence of type IIA and IIX fibres. Snow et al. (1982) used the mATPase stain and gel 
electrophoresis-derived enzyme-linked immunosorbent assay (GEDELISA) to identify the presence 
of type IIA fibres and another type II fibre with a similar oxidative-glycolytic capacity. This type II 
fibre did not correspond to type IIX fibres (called IIB in the paper) in MHC structure and was called 
IIDog fibres. In a study by Latorre et al. (1993) they found similar results to Snow et al. (1982), with 
the presence of type IIA, IIDog and I/II hybrid (referred to as IIC in the paper)  fibres. They believed 
that the IIDog fibres did not correspond to type IIX fibres conventionally found in other species like 
rats. This type IIDog fibre was further investigated in several studies that aimed to achieve a definite, 
unambiguous identification of canine skeletal muscle fibre types and the MHC isoforms they express 
(Acevedo and Rivero, 2006, Strbenc et al., 2004, Toniolo et al., 2007).  Toniolo et al. (2007) found 
that the limb and trunk muscles express MHC I, IIA and IIX and that the type IIDog fibres express 
the MHC IIX isoform. Therefore, type IIDog fibres are those expressing MHC IIX and could be type 
IIX and type IIAX hybrid fibres (Strbenc et al., 2004). The MHC IIA isoform was the most abundant 
with IIX commonly expressed as IIA/IIX hybrids. An oxidative type IIX fibre has also been found in 
antelope species such as the fallow deer and springbok, which may help these animals maintain high 
running speeds for an extended period of time (Curry et al., 2012). These oxidative IIX fibres may 
correspond to the type IIDog (IIX) fibre.  
In an interesting study by Acevedo and Rivero (2006), they investigated a quantitative 
immunohistochemical approach to characterise hybrid canine skeletal muscle fibres. Their rationale 
was that many previous studies do not consider the hybrid phenotype - in terms of determining the 
dominance of one MHC isoform to another.  Yet, hybrid fibres play an essential role in enabling a 
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muscle to fine tune its efficiency and in forming the bridge between “pure” fibres (Acevedo and 
Rivero, 2006, Stephenson, 2001). Acevedo and Rivero used microphotometric 
immunohistochemistry and SDS-PAGE to show a continuum of histological and 
immunohistochemical staining and semi-quantified the images obtained. The results varied slightly 
across muscle groups. Overall, one third of the fibres were hybrid type IA and IIAX fibres. 
Interestingly, while there were very few “pure” type IIX fibres, most of the type IIAX hybrids had a 
dominance of MHC IIX expression. In contrast, type IIA fibres made up 37% of the fibre composition 
followed by type I fibres with 27% and type IIAX with 25%. This shows the high oxidative capacity 
of dog skeletal muscle which is probably linked to their high endurance ability (Acevedo and Rivero, 
2006, Strbenc et al., 2004). However, a notable limitation of this study was the small sample size of 
four. A further limitation was that an average of 150 fibres were counted in total per muscle group, 
with only 118 fibres counted in the Triceps brachii.  
Overall, the skeletal muscle fibre composition of dogs has been investigated over the past few decades 
with varying results. There seems to be a prevalence of type I and IIA fibres with a higher oxidative 
capacity compared to glycolytic capacity. However, all the studies mentioned above (Acevedo and 
Rivero, 2006, Gunn, 1978, Guy and Snow, 1981, Latorre et al., 1993, Snow et al., 1982, Strbenc et 
al., 2004, Toniolo et al., 2007) had very small sample sizes and did not always differentiate between 
breeds. It would be valuable to investigate these muscle characteristics in a wider variety of dog 
breeds.       
1.10.  Skeletal muscle fibre type as a risk factor for Type 2 Diabetes  
The metabolism of various fibre types plays an important role in overall energy balance in muscle. 
Briefly,  type I fibres rely on oxidative metabolism with higher mitochondrial numbers and a higher 
GLUT4 content compared to type IIA and IIX fibres (Lefaucheur, 2010). This would indicate that 
type I fibres are more sensitive to insulin. In a recent review by Duan et al. (2017), they provided 
evidence and hypothesised whether targeting the re-programming of fibres from type II to type I 
would be a potential therapeutic avenue for the treatment of obesity and T2D. Their hypothesis was 
based on the characteristic of muscle plasticity which indicates that, although the total number of 
muscle fibres in an individual is fixed from the time of birth, the fibre type composition can still be 
altered throughout an animal's life to allow for adaptation to different physiological requirements or 
stressors (Schiaffino and Reggiani, 2011). There are a number of signalling pathways responsible for 
specification of type I and type II fibres during embryonic development as well as muscle plasticity 
in adults, but falls beyond the scope of this thesis (Duan et al., 2017).  
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The clinical implications of skeletal muscle fibre composition and metabolism in relation to obesity 
and T2D have been investigated over the past 30 years. Lillioja et al. (1987) conducted a study looking 
at the insulin action (via glucose uptake) and muscle morphology of the Vastus lateralis in 23 
Caucasian and 41 Pima Indian healthy and lean males. Glucose uptake was determined by 
euglycaemic clamp, while capillary density and fibre type were determined via periodic acid-Schiff 
and mATPase stains, respectively. Notably, there was a significant positive correlation between 
glucose uptake and capillary density (capillaries/mm2), which could be linked to the oxidative 
capacity of the muscle due to the increased capillaries. There was also correlations between glucose 
uptake and the percentage of type I fibres (r = 0.29, at maximal conditions) and the percentage of type 
IIX fibres (r = -0.38, at submaximal conditions). The authors proposed that these differences might 
be attributed to some biochemical differences between the fibre types, especially their oxidative 
capacity.  
In a study conducted 10 years later by Simoneau and Kelley (1997), the oxidative (CS) and glycolytic 
(PFK, GAPDH, HK and PHOS) enzyme activities in the Vastus lateralis of 8 lean non-diabetic, 10 
obese non-diabetic and 8 obese T2D human patients were investigated. The data was expressed as 
the ratio of glycolytic to oxidative activity (PFK/CS, GAPDH/CS, HK/CS, and PHOS/CS). T2D 
patients had a higher ratio of all glycolytic to oxidative enzyme capacity compared to their non-
diabetic counterparts, indicating a higher oxidative capacity in healthy participants.  In a similar study, 
Oberbach et al. (2006) investigated whether the changes in oxidative and glycolytic enzymes related 
to the specific muscle fibre types in healthy and T2D participants. SDH and LDH were used to 
measure oxidative and glycolytic activity respectively, while mATPase activity was used to determine 
fibre type. In the T2D group, there was lower SDH and higher LDH activity than the control group, 
indicating a higher glycolytic capacity. The T2D group also had a significantly higher percentage of 
type IIX (fast glycolytic) fibres and a significantly lower percentage of type I (slow oxidative) fibres 
compared to the control group. The authors hypothesised that the reduced oxidative capacity in the 
muscle of T2D patients was likely due to decreased percentage of oxidative fibres and not due to 
changes in individual muscle fibres. These abovementioned studies point to skeletal muscle fibre type 
being a risk factor for insulin resistance and T2D and warrant further investigation in both the human 
and animal population.   
 
1.11. Anticipated gain in knowledge  
Obesity and T2D has become an increasing concern in both the human and animal population. Dogs 
are a useful model to gain a clearer understanding of the physiology surrounding obesity and T2D 
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because (i) there are clinical similarities between humans and domestic dogs and (ii) domestic dogs 
share the same environment as humans and, therefore, develop obesity and T2D spontaneously.  
Skeletal muscle is important in the uptake of glucose and plays a key role in glucose homeostasis in 
the body. Very little is known about skeletal muscle composition in dogs and whether certain fibre 
types may predispose animals to insulin resistance and diabetes. This study would help to characterise 
the skeletal muscle fibre type composition and metabolism of domestic dogs. This would form the 
basis for future studies in elucidating the mechanisms of acquiring diabetes in dogs. It may also create 
a model for further understanding of the disease in humans, especially surrounding the role of 
ethnicity in predisposition to diabetes. This may provide veterinarians and animal owners with the 
necessary knowledge to treat and prevent diabetes in domestic dogs.     
 
1.12. Aims and Hypothesis 
The primary aim of this study is to investigate the skeletal muscle fibre composition and metabolic 
profile in the Vastus lateralis and Triceps brachii skeletal muscle of 16 breeds (including mixed 
breed) of domestic dogs. The secondary aim is to determine whether the hypothesis, proposed by 
Duan et.al (2017), that type I fibres offer protection against insulin resistance and diabetes is valid 
when compared to predicted breed susceptibility.  
This was achieved through fibre typing of the skeletal muscle and determining the muscle enzyme 
activities of specific marker enzymes in oxidative and glycolytic metabolism.   
The hypothesis is that muscle fibre type and muscle metabolism will differ between the different 
breeds of dogs. Dog breeds with a predicted increased risk of diabetes would have a lower proportion 
of type I fibres.   
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CHAPTER TWO 
2. DESCRIPTION OF DOG BREEDS 
2.1. Introduction 
This study comprised 38 canine muscle samples from the Vastus lateralis and Triceps brachii. The 
samples were acquired through opportunistic sampling from euthanased animals at Rondebosch 
Veterinary Hospital in Cape Town and the Onderstepoort Veterinary Hospital in Pretoria. The cohort 
of samples includes 16 dog breeds of varying ages, sex and weight. The aim of this chapter is to 
provide descriptive characteristics of these breeds, in relation to their physiological and physical 
traits.  
The overall descriptive characteristics of the cohort of canines utilised in this study, are outlined in 
Table 1. 
Table 1. Descriptive characteristic of 38 canines of various breeds. Typical parameters from the literature are 
included for lifespan and mean weight.  
Breed 
Typical 
Lifespan 
(years) 
Typical 
Weight range 
(kg) 
Quantity 
(n) 
Sex 
(n) 
Age 
(years) 
Weight 
(kg) 
Neutered 
(n) 
Boerboel* 10 – 12 65 – 80 2 M 
M 
10 
0.4 
39 
15 
No 
No 
 
Chihuahua* 14 – 18 1 – 3 2 F 
F 
13 
0.5 
5 
3 
No 
No 
 
Chow Chow 10 – 12 23 – 34 1 F 10 22 No 
 
Dachshund 12 – 14 7 – 14 4 F 
M 
M 
M 
8 
14 
9 
8 
10 ± 3 
9 
7 
6 
7 
7 ± 1 
 
Yes 
Yes 
No 
No 
Dobermann 10 – 12 29 – 40 1 F 10 31 Yes 
 
Fox terrier 10 – 13 8 – 10 3 F  
F 
M 
13 
6 
1 
10 ± 5 
5 
9 
-- 
7 ± 3 
 
Yes 
Yes 
Yes 
German pointer 12 – 14 20 – 34 1 M 8 46 No 
 
German shepherd* 10 – 12 34 – 43 2 F 
M 
1 
0.08 
18 
2 
No 
No 
 
Greyhound 15 – 16  24 – 32 1 F 11 12 Yes 
 
Jack Russell terrier 13 – 15 7 – 12 8 M 
M 
M 
M 
6 
10 
8 
6 
8 
13 
9 
8 
No 
Yes 
No 
No 
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Breed 
Typical 
Lifespan 
(years) 
Typical 
Weight range 
(kg) 
Quantity 
(n) 
Sex 
(n) 
Age 
(years) 
Weight 
(kg) 
Neutered 
(n) 
M 
M 
M 
M 
 
10 
18 
18 
18 
12 ± 5 
6 
11 
7 
5 
8 ± 2 
 
No 
Yes 
No 
No 
 
Labrador retriever 10 – 12 25 – 31 4 F 
F 
F 
F 
3 
7 
7 
10 
7 ± 3 
35 
30 
37 
21 
31 ± 7 
 
Yes 
Yes 
No 
No 
Miniature pinscher 10 – 16 3 – 5 2 F 
M 
10 
9 
10 ± 1 
5 
3 
4 ± 1 
 
 No 
Yes 
Mixed breed** -- -- 3 M 
M 
M 
 
4 
15 
10 
10 ± 6 
10 
21 
28 
20 ± 9 
 
No 
Yes 
Yes 
Scottish terrier 12 – 13 8 – 10 2 M 
M 
6 
16 
11 ± 7 
8 
6 
7 ± 1 
 
No 
No 
Pomeranian 12 – 16 2 – 3.5 1 F 9 4 
 
No 
Yorkshire terrier 14 – 16 1 – 4 1 F 10 3 Yes 
Where applicable, data are expressed as mean ± SD or expressed as the individual value. The typical 
characteristics of these animals were obtained from Hill’s Pet Nutrition (Hill’s, 2018), Pedigree (2014) and 
DogTime (2019). M, Male; F, Female. *Breeds that contain a puppy (below the age of 1). **Mixed breed 
contains two animals that are crossed with a German shepherd and one unknown cross. 
2.2. Classification of the different breeds  
Dogs were the first species of animal to become domesticated, although the exact dates are unknown 
with evidence ranging from 100 000 to 14 000 years ago (Bradshaw, 2006). As a result, the domestic 
dog is an extremely diverse species with over 300 breeds recognised by the Fédération Cynologique 
Internationale (FCI), which is the World Canine Organisation (Hedhammar and Indrebo, 2011). 
These animals have been bred over many years for a variety of reasons – from hunting to being 
companion dogs. As a result of the vast range of breeds, kennel clubs have developed all over the 
world with the general aim of advancing and protecting the welfare of dogs, particularly purebred 
dogs. In order to fully describe the recognised breeds, the FCI (and other kennel clubs) have breed 
standards, which describes the characteristics of the dogs within each breed. Dogs with similar traits, 
lineage, appearance or function are clustered into the same group – these groups are determined by 
the respective kennel clubs. However, only purebred dogs are recognised by kennel clubs. The FCI 
recognises 10 groups, each group  encompassing many breeds (Figure 2) (FCI, 2019).  
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An important characteristic of skeletal muscle is its ability to adapt to physiological stress (Schiaffino 
and Reggiani, 2011). Fibre size and fibre type can change according to changes in nerve activity 
patterns, mechanical loading (e.g. exercise) and circulating factors such as hormones. Exercise 
training has been shown to cause changes in fibre type composition, such as endurance training that 
leads to an increase in type I fibres while resistance and sprint training leads to a shift to type II fibres 
(Andersen and Henriksson, 1977, Trappe et al., 2006). Due to genetics, there is also variability in 
fibre type composition between species that echo their physical ability. For example, the lion (Pathera 
leo) has significantly more type IIX fibres and higher glycolytic capacity in the Vastus lateralis 
compared to humans (Kohn et al., 2011), while antelope species such as the blesbok (Damaliscus 
pygargus phillipsi) have higher proportions of type IIX and IIA fibres with higher oxidative capacity, 
the latter to at least stand a chance to out run their predator (Kohn, 2014). The consensus therefore is 
that animals (including humans) that have speed and power have greater proportions of type II fibres, 
whereas those with endurance (especially humans) will harbour a greater number of type I fibres. 
This same pattern may be present in domestic dogs as they all exhibit different physical attributes – 
some have been bred for hunting while others bred for companionship. Therefore, the next section 
will briefly report on the various groupings of canines, their physical and lifestyle characteristics and 
their skeletal muscle fibre type, where available or proposed. Very little information with regards to 
Figure 2. Grouping of different dog breeds according to the Fédération Cynologique Internationale (FCI) breed 
standard. Green rectangles indicate dog breeds included in the study sample. *The Boerboel is a South African breed 
that is not recognised by the FCI, however it is closely related to the Bulldog and Mastiff which fall in Group 2. Mixed 
Breed dogs are excluded from this figure.   
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actual physical strength, maximum sprinting speed and endurance are known as it has not yet been 
scientifically investigated. Thus, the content below are provided as predominantly observations. 
Groups 1: Sheepdogs and Cattledogs 
This group of dogs were bred for the purpose of raising, herding and guarding sheep and other 
livestock (KC, 2019). These dogs usually have thick waterproof coats to protect it from the elements. 
One such breed is the German shepherd, which, according to the FCI, is a versatile working, herding 
and service dog. They were bred from two varieties of German herding dogs with the intention of 
creating a “working dog with high achievements”. This is evident from its worldwide recognition as 
a guide and tracking dog due to its good temperament and obedience. Physically, German shepherds 
are medium to large in size, very powerful and muscular. Based on these characteristics, they may 
have both high endurance and speed and hence, contain a high oxidative and glycolytic capacity with 
a high proportion of type IIA fibres. 
Group 2: Pinschers and Schnauzers 
In general, these dogs were bred to “work” on the farm. The group consists of 52 breeds ranging from 
Rottweilers to miniature schnauzers (FCI, 2019). The Dobermann (or Doberman pinscher) is a 
companion, protection or working dog (FCI, 2019). Dobermanns are physically large, powerful and 
muscular dogs, but not seen as the endurance type. 
The miniature pinscher is considered a house and companion dog and actually forms part of the Toy 
Group in The UK Kennel Club (KC, 2019). They were bred with the purpose of hunting rats and 
other vermin. Miniature pinschers are smaller forms of the German pinscher from which it likely 
originates.  
The boerboel is not recognised by the FCI, but is recognised by the Kennel Union of Southern Africa 
and the American Kennel Club (KUSA, 2016). Historically, the boerboel developed from the 
interbreeding of large bull and mastiff type dogs that were brought to South Africa by various settlers 
in the seventeenth century. They were used as farm dogs – defending the farm from predators, hunting 
game and protecting the family. Boerboels are large, strong, sturdy and very muscular dogs (KUSA, 
2016).  
Generally, the dogs in this group are strong and muscular dogs that were bred for protection. 
Therefore, their muscle characteristics would display strength and speed, a high type IIA and IIX 
fibre content, and be more glycolytic with poor oxidative capacity. 
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Group 3: Terriers 
Dogs in this group tend to be small and energetic. Their ancestors were bred to hunt vermin. The fox 
terrier (smooth and wired hair) originated in Britain in the late 1800s and is considered a medium 
sized terrier. They are active and lively, with alleged high power-to-weight ratio (FCI, 2019). Initially 
bred to hunt foxes, they are considered fearless and would seek out foxes within burrows for the 
hunters (KC, 2019). 
The hunt for rats, badgers and foxes on the Scottish Highlands were the primary reason for the 
breeding of the Scottish terrier. It is a small, short-legged and sturdy dog that is alert and agile despite 
its thick-set build (FCI, 2019).    
The toy-sized Yorkshire terrier was bred in the 1850s to hunt rodents in textile mills and coal mines 
(FCI, 2019). Since the mid-1900s, the Yorkshire terrier has become famous as a companion dog. 
They are very small, alert dogs with a long hanging coat.  
Therefore, the skeletal muscle of this group of canines may display a greater abundance of type I and 
IIA fibres compared to the powerful Pinschers and Schnauzers group. Their muscle may also be more 
oxidative.  
Group 4: Dachshunds 
Three varieties of dachshund – standard, miniature and rabbit dog make up this group. Dachshunds 
have been known since the Middle Ages with the first official kennel club established in 1888. 
Dachshunds were bred to track and hunt deer, badgers and rabbits above and below ground (FCI, 
2019). Due to their low centre of gravity and short legs, they are very versatile hunting dogs 
specifically suited for hunting below ground. Based on these characteristics, one might expect their 
skeletal muscle to have similar oxidative and glycolytic capacity with a tendency for type I and IIA 
fibres.   
Group 5: Spits and Primitive 
This group consists of a 52 dog breeds ranging from the Siberian husky to the Pomeranian (FCI, 
2019). Spitz dogs are characterised by long, thick fur, pointed ears and muzzles. Many of them 
originate from the Arctic regions of Siberia and were developed to hunt, herd and pull sleds. Primitive 
dogs are most likely classified as those who originated outside of Europe, many from South America 
and Asia.  
The Chow Chow is possibly one of the world’s oldest dog breeds with artefacts dating back to China’s 
Han Dynasty in 206 BC. Chow Chows are related to the Nordic spitz and mastiff type dogs. They are 
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medium sized, powerful and muscular in stature and known for their lion-like manes (FCI, 2019). 
The Pomeranian is a miniature descendant of the German spitz that was utilised as a watch and 
companion dog. Pomeranians largely owe their popularity to Queen Victoria who became a breeder 
of Pomeranians in the mid-1800s and is credited for reducing them to toy size (KC, 2019). In other 
kennel clubs they form part of the Toy Group.  
The animals in this group are very diverse and so would have different skeletal muscle characteristics. 
They would likely have similar oxidative and glycolytic capacity with a higher proportion of type IIA 
fibres.  
Group 7: Pointers 
Pointers and setters are a type of Gundog (or bird dogs) that instinctively point towards game with 
their muzzles, directing the hunter towards the game. German pointers (or German pointing dogs) 
can be divided into shorthaired and wirehaired. Although they are not directly related to one another, 
they are both versatile hunting dogs for land and water (FCI, 2019). Pointers are medium to large in 
size, with a high endurance enabling them to spend hours wading through water and bushes. Their 
skeletal muscle would likely reflect this endurance ability with higher oxidative capacity and a higher 
proportion of type I and IIA fibres.  
Group 8: Retrievers – Flushing – Water Dogs 
This group consists of Gundogs that primarily flush and retrieve birds and game from land or water. 
The Labrador retriever is believed to have originated on the coast of Newfoundland as a water dog 
that retrieved fish for the local fisherman (FCI, 2019). Labradors are preferred to act as guide dogs, 
service dogs and as companions. It is a large, strong, athletic dog with a water-resistant coat. It is 
capable of working long hours under difficult conditions as a Gundog. Therefore, the Labrador 
retriever would likely have similar skeletal muscle characteristics as the Pointers Group – higher 
oxidative capacity with more type I and IIA fibres.  
Group 9: Companion and Toy 
Dogs in this group were bred as small companions for humans. The Chihuahua originated in Mexico 
and is considered the smallest companion dog (FCI, 2019). Its ancestor, the Techichi, was an integral 
part of the Aztec culture in the 12th century. It has become famous in recent years as a “purse dog” 
due to its small, compact size. The Chihuahua has limited endurance and prefers short, slow walks. 
The skeletal muscle of the Chihuahua may have similar glycolytic and oxidative capacity with a 
higher proportion of type IIA and IIX fibres.  
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Group 10: Sighthounds 
Sighthounds are hunting dogs that hunt by sight and speed as opposed to scent. The greyhound, which 
could be considered the flagship dog of this group, is believed to have originated in Ancient Egypt in 
4000 BC. With its long, streamlined body, it is the fastest dog breed reaching speeds of 70 km/h (FCI, 
2019). In an early study by Gunn (1978), they found that greyhounds had 97% type II fibres (using 
mATPase stain) in the semitendinosus muscle. Based on the high speed characteristics of the 
greyhound, higher proportions of type IIX fibres with high glycolytic capacity would be expected.  
2.3. Limitations of the study sample 
There are several limitations with this study sample. To start, the clinical reasons for euthanasia were 
not disclosed. The majority of the animals were older than 10 years, and as a result, “old age” was 
often recorded as the reason for euthanasia. This may have implications on the results, specifically 
the metabolism of the muscle and muscle fibre size. Secondly, as the sampling was opportunistic – 
thus, the breed, sex and age of the samples could not be controlled for or anticipated. Therefore, there 
are many breeds in this cohort with a sample size of only one or two.  
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CHAPTER THREE 
3. SKELETAL MUSCLE MORPHOLOGY  
3.1. Background 
Previous studies have shown that the skeletal muscle of domestic dogs have a prevalence of Type I 
and IIA fibres with very few Type IIX fibres. However, most of these studies have contrasting results 
that may be due to their small sample size, limited dog breeds and, in some cases, minimal fibres 
counted and techniques not able to distinguish between the three fibre types (Acevedo and Rivero, 
2006, Guy and Snow, 1981, Snow et al., 1982). Skeletal muscle plays a major role in maintaining 
glucose homeostasis with Type I fibres linked to increased insulin sensitivity and that potentially 
targeting these fibres may provide therapeutic treatment for obesity and T2D (Duan et al., 2017). This 
chapter aims to investigate the fibre type composition and cross sectional area of the VL and TB 
muscles in 16 different breeds of domestic dogs. The aims are: 
 to support or provide new findings of previous studies (where data is available), 
 to provide the fibre type profiles of the 16 breeds, and  
 to assist in providing evidence for the proposed hypothesis that fibre type is associated with 
insulin resistance and T2D. 
3.2. Methodology 
3.2.1. Study Animals 
The study sample included 38 dogs of various breeds, age, sex and weight (Table 1). These animals 
were euthanased for reasons not disclosed to the researchers. Sampling was opportunistic and 
collection took place at the Onderstepoort Veterinary Academic Hospital in Pretoria, as well as the 
Rondebosch Veterinary Hospital in Cape Town, with consent from the owner. 
3.2.2. Ethics   
Ethical approval for this study was obtained from the Faculty of Health Science Animal Ethics 
Committee, University of Cape Town (reference number: 017/023) and the Faculty of Veterinary 
Science Animal Ethics Committee, University of Pretoria (reference number: v026-18). A 
Department of Agriculture, Forestry’s and Fisheries Section 20 permit was also granted for the 
research.         
 33 
3.2.3. Tissue collection  
Muscle samples were collected post mortem according to the procedure described by (Hennessey et 
al., 1997, Kohn et al., 2011). No animals were euthanased for the purposes of this study. Biopsies of 
approximately 50 to 100 mg were obtained from the VL and lateral head of the TB. After collection, 
the samples were cut into smaller pieces and rapidly frozen in liquid nitrogen. Samples were 
transported on dry ice to the Division of Exercise Science and Sports Medicine, Newlands and stored 
at -80°C until analyses. 
3.2.4. Section preparation, fibre typing and fibre cross sectional area (CSA) 
The fibre type of each VL and TB muscle sample was determined by fluorometric 
immunohistochemistry as described by Fry et al. (2014) with modifications. The frozen muscle 
samples were sectioned using a cryostat set to -25˚C (Leica CM1100, Leica Biosystems) into 10µm 
thick serial cross sections and each section placed onto a microscope slides. Slides were stored at -
20°C until processed.  
Slides were removed from the -20°C and allowed to air dry. The sections were fixed in acetone at -
20˚C for 2 minutes, dried and hydrated in PBS. After blocking non-specific binding sites with 5% 
donkey serum (made up in PBS) for 1 hour at room temperature, the sections were incubated 
overnight at 4°C with primary antibodies against the MHC corresponding to type I (BA-D5) and type 
IIA (SC71) fibres. Type IIX fibres were lightly stained by SC71. All primary antibodies were 
purchased from Developmental Studies Hybridoma Bank (Iowa, USA). The following day, slides 
were washed in PBS and then incubated for one hour at room temperature with fluorescently-tagged 
secondary antibodies, namely AMCA goat anti-mouse IgG2b (catalogue number: 115-155-207) and 
AlexaFlour 488 goat anti-mouse IgG1 (catalogue number: 115-545-205) purchased from Jackson 
ImmunoResearch Laboratories. After washing in PBS, cover slips were mounted with a fluorescent 
mounting medium (Moviol) containing antifade and stored at 4°C until imaging.  
Sections were visualised with a fluorescent microscope (Nikon Eclipse 80i, New York, USA) and 
photographs taken of a selected section at 10x magnification using a digital camera (Canon EOS 
650D, Pretoria, South Africa).  The number of fibres per fibre type was counted for a selected area of 
the section and expressed as a percentage of the total number of fibres counted. The fibres were 
classified as pure type I, IIA or IIX fibres (Figure 3A) with an average of 700 fibres counted and 
typed per section. Hybrid type IA and IIAX fibres were identified, but made up less than 2.5% per 
hybrid type of the total fibre type composition. As a result, the percentage of hybrid fibres were 
divided and included in the type I, IIA or IIX category e.g. the percentage of type IA hybrids were 
halved and included in the type I and IIA groups. The CSA of a maximum of 50 fibres per fibre type 
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were determined per section using the computer programme ImageJ (version 1.50e, Maryland, USA). 
The image was broken up into quintiles (five areas) and the CSA of 10 fibres of each fibre type in 
each section was determined and averaged, this was to ensure that the entire muscle section was 
represented. A more detailed protocol described in Appendix A.  
3.2.5. Statistical analyses 
Statistical calculations were performed using GraphPad Prism 7.0e (GraphPad Prism, La Jolla, CA, 
USA). Values are expressed as mean ± standard deviation and normality was checked with the 
Shapiro-Wilks normality test. Statistical analyses were not performed between different breeds as the 
sample sizes were too small. However, the fibre type and fibre CSAs from the VL and TB were 
compared to one another using the non-parametric Kruskal- Wallis one-way ANOVA multiple 
comparison test. The relationship between CSA and the weight of the animals were determined using 
a non-linear regression fit (two-phase decay for line of best fit). Significance was set at P < 0.05.  
3.3. Results 
3.3.1. Fibre type composition 
In the TB and VL of all adult animals grouped (Figure 3B), type IIA fibres were the predominant 
fibre type with 43% ± 11 and 44% ± 18 respectively. This was followed by type I fibres with 33% ± 
14 and 38% ± 27%, whereas type IIX fibres represented 24% ± 16 and 18% ± 18, respectively. Using 
the Kruskal-Wallis ANOVA test, there was no significant difference between the TB and VL in type 
I, IIA or IIX fibres. All the fibre types had a large standard deviation, which is apparent when the 
spread of the individual animals is examined (Figure 3B).  
Figure 3C and D shows the fibre type composition according to their breed, with each breed grouped 
according to the FCI breeding group standards. The German shepherd had a higher percentage of type 
IIA fibres (TB: 44%; VL: 49%) with an equal amount of type I and IIX fibres. The Dobermann had 
a higher percentage of type IIA fibres (TB: 50%; VL: 75%) followed by type I fibres (TB: 39%; VL: 
21%). The VL of the miniature pinscher appears to have a distinct different fibre type profile than its 
TB. Type IIA dominated in the TB (54% ± 3) and type I dominated in the VL (49% ± 59). However, 
there was a large standard deviation in all the fibre types in the VL muscle group, and might be a 
sampling error. This was followed by 33% ± 3 type I, 13% ± 0 type IIX (TB) and 28% ± 27 type IIA, 
23% ± 33 type IIX (VL). The boerboel also had contrasting TB and VL profiles with type IIX fibres 
having a higher percentage on average. The type I, IIA and IIX proportions were 29%, 29% and 42% 
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in the TB and 10%, 48% and 42% in the VL. Overall, the Pinschers and Schnauzers group had a fibre 
type composition of 33%, 47%, 20% and 32%, 45%, 23% for TB and VL, respectively.  
The Terrier group had an average type I, IIA and IIX distribution of 30%, 43%, 27% and 42%, 41%, 
17% for TB and VL, respectively. The fox terrier had predominantly type IIA fibres in the TB and 
VL (44% ± 4 and 48% ± 9) followed by type I fibres (39% ± 15 and 23% ± 18). The Scottish terrier 
had a similar percentage of type IIA fibres in the TB and VL (44% ± 14 and 47% ± 13), but a higher 
percentage of type IIX fibres in the TB and VL than type I (33% ± 29 and 37% ± 27). The Jack 
Russell had the largest sample size group, with 8 animals. Its fibre type composition were 
predominantly type IIA (44% ± 11) and type I (30% ± 10) in the TB. The VL had a predominance of 
type I fibres (57% ± 24) followed by type IIA fibres (37% ± 20). Unlike the other terriers, the 
Yorkshire terrier had a higher proportion of IIX fibres (48%) and IIA fibres (30%) in the TB. While 
each fibre type proportion was approximately 33% in the VL.  
The fibre type distribution of the TB and VL of the dachshund were similar with a slightly higher 
percentage of type I fibres (40% ± 19 and 42% ± 31%). This was followed by type IIA (35% ± 8 and 
36% ± 8) and type IIX fibres (25% ± 16 and 22% ± 25). There was a large standard deviation between 
the four samples, especially for type I and IIX fibres.  
The Spits and Primitive group consisted of a Chow Chow and Pomeranian. The fibre type 
composition in the TB of these two breeds appeared the same (I: 20% ± 0.5; IIA: 36% ± 0.3; IIX: 
44% ± 0.3).  On the other hand, the fibre type seems to be vastly different for the VL, with the Chow 
Chow having 70% type I and 30% type IIA and no type IIX fibres. In contrast, the Pomeranian had 
49% type IIX, 40% type IIA and 11% type I fibres. This could potentially be due to sampling error. 
The German pointer and Labrador retriever fall under the Pointer and Retriever-Flushing-Water dog 
groups, respectively, which are both largely classified as Gundogs. In the TB of the German pointer, 
the proportion of type I, IIA and IIX fibres were 47%, 50% and 3% while the proportions in the VL 
were 60%, 32% and 8%, respectively. There were four Labradors included in the sample group that 
appears to have a similar fibre type composition for the TB (I: 40% ± 22; IIA: 43% ± 14; IIX: 17% ± 
20), but more type IIA fibres in the VL (I: 36% ± 31; IIA: 55% ± 29; IIX: 9% ± 7).  
The Chihuahua, which falls under the Toy and Companion dog group, had a similar fibre type 
composition in both the TB and VL. Type IIA was the predominant fibre type (TB: 58%; VL: 46%) 
followed by type I (TB: 23%; VL: 25%) and type IIX fibres (TB: 19%; VL: 30%). The greyhound, 
considered the fastest of the canines, seems to have the lowest proportion of type I fibres of all the 
dogs (TB: 13%; VL: 2%). As a result, it had a high percentage of type IIA (TB: 50%; VL: 76%) and 
IIX fibres (TB: 37%; VL 22%).  
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The mixed breed category contained dogs with an incomplete breed history. On average, there was a 
higher proportion of type IIA fibres (TB: 57% ± 4; VL: 48% ± 18). The remainder comprised of type 
I (TB: 34% ± 12; VL: 39% ± 29) and type IIX fibres (TB: 10% ± 9; VL: 14% ± 12).  
There were three puppies (dogs below the age of one) included in this cohort and they were grouped 
separately. The boerboel puppy had noticeably more type I fibres compared to the adult, with 43% 
and 56% for the TB and VL, respectively. Type IIA and IIX fibres represented 31% and 26% in the 
TB and 38% and 6% in the VL. The German shepherd appeared to have a higher proportion of type 
I (TB: 48%; VL: 35%) and IIA fibres (TB: 40%; VL: 56%) compared to the adult. In contrast, the 
Chihuahua puppy seemed to have a higher proportion of type IIX fibres (TB: 51%; VL: 27%) 
compared to the adult Chihuahua. The distribution of type I and IIA fibres were 20% and 30% in the 
TB and 9% and 65% in the VL.     
 
3.3.2. CSA 
The average CSA of type I, IIA and IIX fibres in the TB and VL is shown in Figure 4A. The average 
CSA of all the adult animals in the TB was 1740 µm2 ± 586 for type I fibres, 1690 µm2 ± 606 for type 
IIA fibres and 1726 µm2 ± 674 for type IIX fibres. The VL had similar CSA of 1712 µm2 ± 613 (type 
I), 1720 µm2 ± 733 (type IIA) and 1791 µm2 ± 890 (type IIX). There was no significant difference 
between type I, IIA and IIX fibres of the TB and VL using the Kruskal-Wallis ANOVA. Due the 
apparent similar CSA of type I, IIA and IIX fibres they were grouped together for each breed 
(excluding the puppies) and an average CSA determined (Figure 4B). The shaded area of Figure 4B 
represents the range of CSA from previous human studies conducted in the same laboratory (Kohn et 
al., 2011, Kohn et al., 2007a). 
The range of average CSA in the TB was 1030 µm2 to 3898 µm2. The German pointer had the largest 
fibres of 3898 µm2 with no other breed having a CSA of greater than 3000 µm2. The mixed breed 
(2078 µm2 ± 510) and the Labrador (2006 µm2 ±497) had the second and third largest CSA values, 
respectively. As expected, the Yorkshire terrier had the smallest CSA of 1030 µm2 followed by the 
miniature pinscher at 1205 µm2 ± 228.  
The range of average CSA in the VL was 770 µm2 to 2758 µm2. The boerboel had the largest CSA 
followed by the Labrador (2188 µm2 ± 1034), mixed breed (2163 µm2 ± 831) and Chow Chow (2161 
µm2). The breeds with the smallest CSA were the Yorkshire terrier (770 µm2), miniature pinscher 
(867 µm2 ± 384) and Chihuahua (1237 µm2).  
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The three puppies included in the sample all had lower CSA compared to their respective adults. The 
Chihuahua had an average CSA of 1034 µm2 (TB) and 1630 µm2 (VL), respectively, while the 
boerboel had similar TB and VL values of 1207 µm2 and 1111 µm2 (VL). The German shepherd had 
the smallest CSA (TB: 479 µm2; VL: 519 µm2), but it was also the youngest animal (4 weeks).   
Figure 3. (A) Immunohistochemistry of a cross sectional cut of the Vastus lateralis in a dog sample. The blue 
fluorescence indicates type I fibres, the bright green fluorescence indicates type IIA and the lightly stained green 
indicates type IIX fibres. The image was captured at 10x magnification. (B) The fibre type composition (%) of the Triceps 
brachii (TB) and Vastus lateralis (VL) of 38 samples. The circles represent individual values, the bars represent mean 
± SD. Black bars represent type I fibres, dark grey represents type IIA, light grey represents type IIX. (C-D) The fibre 
type composition (%) in relation to overall total composition in the Triceps brachii and Vastus lateralis of each breed 
contained in this study, breeds are further grouped into their respective FCI breed group. The puppies (below the age 
of one) are displayed separately. Bars represent either mean or mean ± SD. Black bars represent type I fibres, dark 
grey represents type IIA, light grey represents type IIX. 
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3.3.3 Correlation between CSA and body weight  
The correlation between the CSAs of the type I, IIA and IIX fibres and the weight of the animal was 
investigated using non-linear regression (Figure 5). The curve on the figure is representative of all 
the fibres grouped together. The TB has a stronger correlation (r2=0.40) than the VL (r2=0.32). 
Noticeably, the majority of the weight falls below 20 kg and, therefore, the data is clustered at the 
bottom of the graph.   
Figure 4. (A) The cross sectional area (CSA, 
µm2) of the Triceps brachii (TB) and Vastus 
lateralis (VL) of 38 samples. The circles 
represent individual values, whilst the bars 
represent mean ± SD. Black bars represent 
type I fibres, dark grey represents type IIA, 
light grey represents type IIX.  The shaded 
grey area represents the range of human 
CSA from previous studies. (B) The CSA 
(µm2) in the Triceps brachii and Vastus 
lateralis of each breed contained in this 
study. Breeds are further grouped into their 
respective FCI breed group. The puppies 
(below the age of one) are displayed 
separately. Bars represent either mean or 
mean ± SD. Black bars represent TB, grey 
bars represent VL. The shaded grey area 
represents the range of human CSA from 
previous studies.  
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3.3. Discussion 
3.3.1. Fibre type composition 
In this study, the predominant fibre type was the fast twitch oxidative type IIA fibre, followed by type 
I and IIX. This finding was evident in both the TB and VL muscle groups and is supported by previous 
research in dogs, including muscle groups such as the Semitendinosus, Longissimus dorsi, TB and 
VL (Acevedo and Rivero, 2006, Guy and Snow, 1981, Latorre et al., 1993, Strbenc et al., 2004, 
Toniolo et al., 2007). Acevedo and Rivero (2006) found that dog muscle fibres expressing MHC IIX 
were only found in the Latissimus dorsi, Gluteus medius and Semitendinosus (averaging 8% of the 
muscle fibres). Type IIX fibres were not found in the TB or Vastus intermedius. Acevedo and Rivero 
(2006) also found that hybrid IA and IIAX comprised 28% of the total fibres across all muscle groups. 
Toniolo et al. (2007) used gel electrophoresis to determine the percentage of type IIX fibres in dog 
muscle. They found that type IIX fibres represented on average 22% of the five muscle groups 
investigated, but not all the muscle groups investigated expressed IIX fibres. The authors concluded 
that type IIX fibres are present in most, but not all limb muscles while type IIA fibres were the most 
abundant fibre type present. In the present study, 24% and 18% of the total fibres analysed were type 
IIX in the TB and VL, respectively (Figures 3B – D) and corresponds to the study by Toniolo et al. 
(2007). The major limitation of those studies was that very few fibres were studied in total across all 
muscle groups (Acevedo study: 1083 fibres; Toniolo study: 247 fibres) and that may account for the 
differences observed in the present study. A total of 52 000 fibres were counted for the TB and VL 
Figure 5. The correlations between CSA (µm2) and animal weight in the (A) Triceps brachii and (B) Vastus lateralis. The 
circles represent type I (white), IIA (grey) and IIX (black) of each individual animal. The curve represents the non-linear 
regression of all fibre types grouped together.  
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across sixteen breeds of domestic dogs in the present study. There were limited number of hybrid 
fibres (IA and IIAX) identified in the present study with only 5% identified in the TB and 6% in the 
VL. The low number of hybrid fibres may be due to the difficulty in identifying them through 
immunohistochemistry where type I, IIA and IIX fibres are clearly visible using the specific 
antibodies (Figure 3A). Alternatively, the high number of hybrid fibres may be due to inaccuracies in 
the Acevedo and Rivero (2006) study.  
The proportions of type I, IIA and IIX fibres varied between the different FCI recognised groups as 
well as between the breeds. It is important to note that there were many breeds with a sample size of 
one (greyhound, Chihuahua, German pointer, Pomeranian, Chow Chow, Yorkshire terrier, 
Dobermann, boerboel and German shepherd) and therefore references to the results of these breeds 
are more indicative of a case study. From Figure 3C, the following breeds had higher proportions of 
type I and IIA fibres in the TB – Chihuahua, Labrador, German pointer, dachshund, fox terrier and 
Dobermann. While the breeds with a higher proportion of IIX fibres were the greyhound, Pomeranian, 
Chow Chow, Yorkshire terrier and boerboel.  
However, this same pattern was not observed in the VL (Figure 3D), with Labrador, German pointer, 
Chow Chow, Jack Russell and miniature pinscher displaying on average a greater proportion of type 
I and IIA fibres. The Pomeranian, Scottish terrier and boerboel had higher proportions of type IIX 
fibres. Overall, the Labrador and German pointer had consistently higher numbers of type I and IIA 
fibres, which ties in well with their breed characteristic as Gundogs that have high endurance in order 
to retrieve game (FCI, 2019). The Pomeranian and boerboel seemed to have consistently higher 
proportions of type IIX fibres and matches the powerful characteristics of the latter breed, but is 
somewhat unexpected for the small Pomeranian (FCI, 2019). There were several dogs with thought-
provoking fibre type profiles. In the VL, the greyhound only had 2% type I fibres, 76% type IIA and 
22% type IIX fibres. This proportion is similar to previous reports on the VL of the greyhound of 
96% type II fibres (IIA and IIX) – an expected composition due to their high athletic ability as race 
dogs (Guy and Snow, 1981). The Chow Chow had no type IIX fibres in the VL, but they were present 
in the TB. This was also seen in an individual dachshund, Jack Russell and miniature pinscher and 
the VL of a Labrador. The lack of type IIX fibres is likely due to the section of the skeletal muscle 
sample (Delp and Duan, 1996, Gunn, 1978) and is not necessarily indicative of a total lack of type 
IIX fibres in the muscle. Indeed, this hypothesis is confirmed in the analyses of the enzyme and MHC 
isoform content of a separate sample (Chapter 4). The MHC isoform content was investigated for 
each sample (data not shown) as an alternative method for fibre typing. There were high positive 
correlations between MHC isoform content and fibre type proportions for I, IIA and IIX respectively. 
This indicates that differences are not likely due to the method. 
 41 
The Chihuahua, German shepherd and boerboel puppy had similar fibre type composition in the TB 
and VL. However, all three had different compositions to their respective adults – namely a higher 
percentage of type I fibres. This difference in fibre type, especially in the 4 week old German 
shepherd, may be due to their developing skeletal muscle (Schiaffino and Reggiani, 2011).  
 
3.3.2. Fibre type and diabetes risk 
In the comprehensive review by Hoenig (2014), the author used different epidemiological studies to 
identify which dog breeds were at a high or low risk for developing diabetes. According to Duan et 
al. (2017), fibre type composition is a potential risk factor in developing T2D. They proposed that the 
reprogramming of fibres to the more insulin sensitive type I fibres would be protective against the 
disease. Based on this concept, dogs with a higher proportion of type I fibres may be at a lower risk 
of developing T2D, while those with a lower proportion of type I fibres may be at a higher risk.  
According to Hoenig (2014), the fox terrier (and potentially the Terrier group in general) have a 
higher incidence of T2D. In the present study, the fox terrier had a high proportion of type I fibres in 
the TB and a lower proportion in the VL (Figure 3C and D). This same pattern was observed for the 
Yorkshire terrier while the Jack Russell had a consistently higher percentage of type I fibres. Only 
the Scottish terrier had low type I fibres in both muscle groups. Based on these findings and the 
proposed hypothesis by Duan et al. (2017), it appears that only the Scottish terrier would be at an 
increased risk for developing T2D. The high risk category also included Samoyeds and Swedish 
elkhunds and lapphunds which form part of the Spits and Primitive Group (FCI, 2019, Hoenig, 2014). 
The present cohort did not contain those three breeds, but it did contain the Chow Chow and 
Pomeranian which fall into the same group. The Pomeranian had a lower proportion of type I fibres 
in the TB and VL, while the Chow Chow had a low proportion in the TB, but not in the VL. 
Interestingly, both dogs have approximately the same fibre type composition in the TB. This could 
indicate that dogs within this group are not as varied with their fibre type composition and as a result, 
fibre type composition may be a risk factor in their high T2D incidence.  
Dogs at lower risk for developing T2D include the cocker spaniel and golden retriever (Retriever 
Group), and collie and German shepherd (Sheepdogs and Cattledogs Group) (FCI, 2019, Hoenig, 
2014). In this study, the Labrador forms part of the Retriever group and the German pointer forms 
part of the closely related Pointer Group. Both dog breeds had a high proportion of type I fibres and 
a very low proportion of IIX fibres. This finding suggests that the hypothesis proposed by Duan et al. 
(2017) may be true, in that a high proportion of type I fibres would lead to lower risk of T2D. 
However, the German shepherd had lower proportions of type I fibres compared to the Labrador and 
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German pointer. The dachshund and Jack Russell also had high proportions of type I fibres, however 
their risk for T2D is unknown.  
There does seem to be trends surrounding fibre type and potentially correlating it to the incidence of 
diabetes, however, no definitive conclusion can be drawn from these findings. The results in this 
study are cross sectional in nature and the reasons why these animals were euthanased were also not 
disclosed. Ideally, the skeletal muscle composition should be investigated in a population of diabetic 
animals and healthy controls of the same age. Additionally, an intervention study to evaluate fibre 
type by inducing insulin resistance and T2D in an animal model would be better suited to prove or 
disprove the hypothesis that type I fibres decreases the risk of acquiring T2D. This may be an avenue 
for future studies.  
 
3.3.3. Cross sectional area and correlations 
The average fibre CSA determined in this study was 1729 µm2 across all fibre types in the TB and 
VL. There was no distinguishable difference in CSA between type I, IIA and IIX fibres across the 16 
breeds. This value is slightly lower than what was reported by Acevedo and Rivero (2006) who 
investigated the CSA in different muscle groups in the dog. That study reported that the average CSA 
of type I and IIA fibres in the TB and Vastus intermedius was 2218 µm2 (I), 1446 µm2 (IIA) and 1925 
µm2 (I), 2805 µm2 (IIA), respectively. The CSA of type IIX fibres was not determined in these muscle 
groups, but was 2357 µm2 in the Latissimus dorsi. 
Comparatively, the CSA in the VL of humans are 5409 µm2 (I), 5174 µm2 (IIA) and 2968 µm2 (IIX) 
(Kohn et al., 2011). In that same study, the CSA of captive lions were 2014 µm2 (I), 2005 µm2 (IIA) 
and 3202 µm2 (IIX), while the caracal had similar CSAs as the lion, even though there is an 
approximately ten-fold difference in body weight between these two species. The CSA of the dog 
breeds in the present study were markedly smaller than humans and similar to that of captive lions 
and a caracal. As stated by Kohn et al. (2011), a smaller CSA does not necessarily mean that the 
muscle generates less power as this is dependent on other factors such as the number of muscle fibres 
recruited, fibre proportions and ATP supply. However, the present study did not investigate the 
skeletal muscle power production in the various breeds of the dog. 
Based on Figure 5, it appears that there is a slight positive correlation between the weight of the dog 
and the CSA. Therefore, the larger the dog, the larger the CSA of the muscle fibres. The significance 
of fibre size in relation to the risk of developing insulin resistance is yet to be determined.  
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CHAPTER FOUR 
4. SKELETAL MUSCLE METABOLISM 
4.1. Background 
The skeletal muscle of dogs have been shown to have a high oxidative capacity (Acevedo and Rivero, 
2006, Gunn, 1978, Guy and Snow, 1981). Previous studies have used various enzymes as markers of 
oxidative and glycolytic capacity. In the present study, the markers of oxidative capacity include CS 
and 3HAD, which are marker enzymes of the Kreb’s cycle and β-oxidation, respectively. CS is also 
a marker of mitochondrial content. CK and LDH act as markers of the high energy phosphate pathway 
and glycolytic capacity, respectively. This chapter aims to investigate the CS, 3-HAD, CK and LDH 
enzyme activities in the TB and VL of 16 breeds of domestic dogs.  
4.2. Methodology 
4.2.1. Sample  
The maximum enzyme activities (CK, LDH, CS, 3HAD) were determined in the TB and VL muscle 
from 38 dogs. 
4.2.2. Sample preparation for enzyme assays   
Muscle samples were homogenised and prepared for enzyme analyses according Kohn et al. (2007b), 
with slight modifications. An amount of 10 to 20 mg wet weight muscle tissue was weighed. The 
samples were diluted to a ratio of 1:100 (1 mg muscle to 100 µl buffer) with 0.1M potassium 
phosphate buffer, pH 7.3. The muscle piece was homogenised by hand using a glass homogeniser, 
followed by five times pulse sonication (Qsonica sonicators) for 10 seconds (one second pulse 
interval at 30% amplitude) on ice. See Appendix B for homogenising buffer preparation.        
4.2.3. Homogenate protein concentration 
The total protein concentration of each muscle homogenate was determined using the Bradford assay 
(Bradford, 1976).  Bovine serum albumin (BSA) standards of 0 to 3 g/l (0.5 g/l increments) were used 
to construct a standard curve of known protein concentrations.  Performing in duplicate, 5 µl of each 
dog homogenate was pipetted into a clear 96-well microplate, followed by 250 µl Bradford solution. 
The reaction was left to incubate for 5 minutes at room temperature, and the absorbance analysed at 
 44 
595 nm using a microplate reader (BioTek Synergy HT). Using the BSA standard curve generated, 
the unknown protein concentration was calculated.  
4.2.4. Fluorometric enzyme assays 
The following enzymes were analysed fluorometrically to determine the maximum flux capacity 
through various metabolic pathways: CK, LDH, CS and 3HAD. The role of the each of these enzymes 
have been described in chapter 1.  
These enzyme assays were based on the conversion of NAD(P)H to NAD(P)+ (or vice versa) as the 
reaction progresses. Maximum enzyme activity was measured using fluorometry, in which the 
fluorescence of the reduced forms of NAD and NADP was determined at known time intervals. All 
reactions occurred at 25°C with an excitation and emission wavelength of 340 nm and 460 nm, 
respectively. The slope of fluorescence over time was calculated and converted to moles substrate 
using the NADH or NADPH standard curve. Maximum enzyme activity was expressed as 
µmol/min/g protein. A detailed protocol for each assay is described in Appendix B.    
4.2.5. Statistical analyses 
Statistical calculations were performed using GraphPad Prism 7 (GraphPad Software Inc, USA). 
Values are expressed as mean ± standard deviation and normality was checked with the Shapiro-
Wilks normality test. The data were not normally distributed and a Kruskal- Wallis one-way ANOVA 
multiple comparison was used. The CK, LDH, CS, and 3HAD enzyme activities for all the animals 
combined were compared between the TB and VL. Statistical analysis was not performed between 
the different breeds as the sample sizes were too small. Significance was set at P < 0.05. 
4.3. Results 
4.3.1. Oxidative capacity  
CS and 3-HAD activities are markers of oxidative capacity in the skeletal muscle of the various dog 
breeds (Figure 6A and B, Appendix B). In the TB and VL, the average CS activity across all the 
breeds was 61 ± 16 µmol/min g protein and 49 ± 13 µmol/min/g protein, respectively, while the 
average 3HAD activity was 53 ± 14 µmol/min/g protein (TB) and 46 ± 16 µmol/min/g protein (VL). 
There was no significant difference between the CS and 3HAD activities between the TB and VL. 
On the same figure, the average activities of recreationally active and endurance human athletes are 
shown for comparative purposes. This data was collected in the same laboratory and the average of 
six recreational and endurance athletes were used. These values are routinely used as reference points. 
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The CS activity of the recreationally active participants were 27 ± 7 µmol/min/g protein, while the 
endurance athletes had more than double the amount at 57 ± 17 µmol/min/g protein. The 3HAD 
activity of the same participants were 43 ± 12 µmol/min/g protein (recreational) and 90 ± 15 
µmol/min/g protein (endurance).  
The range of CS activities in the TB was 38 to 80 µmol/min/g protein, while the range in the VL was 
similar at 33 to 66 µmol/min/g protein. In the TB, the dachshund had the highest activity followed by 
the Dobermann (77 µmol/min/g protein) and Scottish terrier (72 ± 21 µmol/min/g protein), while the 
lowest activities were recorded for the Chow Chow, German pointer (43 µmol/min/g protein) and 
Yorkshire terrier (44 µmol/min/g protein). The breeds with the highest CS activities in the VL were 
the Dobermann, Chihuahua (64 µmol/min/g protein) and greyhound (63 µmol/min/g protein) and the 
breeds with the lowest activities were the German pointer, boerboel (36 µmol/min/g protein ) and 
miniature pinscher (37 ± 0.5 µmol/min/g protein).  
The range of 3HAD activities in the TB and VL were very similar at 29 to 78 µmol/min/g protein and 
28 to 73 µmol/min/g protein, respectively. The Dobermann (TB: 78 µmol/min/g protein; VL: 73 
µmol/min/g protein) and German shepherd (70 µmol/min/g protein in both groups) had the highest 
activities in both muscle groups. The Chow Chow consistently had the lowest activities (TB: 29 
µmol/min/g protein; VL: 32 µmol/min/g protein) along with the German pointer (TB: 43 µmol/min/g 
protein) and boerboel (VL: 28 µmol/min/g protein).  
The boerboel, German shepherd and Chihuahua puppies had similar CS and 3-HAD activities 
compared to their corresponding adults. The Chihuahua (TB: 72 µmol/min/g protein; VL: 45 
µmol/min/g protein) had a higher average CS activity than the German shepherd (TB: 44 µmol/min/g 
protein; VL: 52 µmol/min/g protein) and boerboel (TB: 50 µmol/min/g protein; VL: 46 µmol/min/g 
protein).  
 
4.3.2. Glycolytic capacity  
LDH and CK activities are markers of the glycolytic capacity as shown in Figure 6C and D and 
Appendix B. The average LDH activity across all dog breeds was 1550 µmol/min/g protein ± 592 in 
the TB and 1478 µmol/min/g protein ± 658 in the VL. In the TB and VL, the average CK activity 
was 6115 ± 1081 and 6279 ± 1529 µmol/min/g protein, respectively. There was no significant 
difference between the LDH and CK activities between the TB and VL. Comparatively, the LDH 
activity of the recreationally active humans were 331 ± 165 µmol/min/g protein and for the endurance 
athletes 557 ± 167 µmol/min/g protein. These values are two to three times lower than the dog 
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activities. The CK activities of the recreationally active and endurance athletes were 5897 ± 1003 
µmol/min/g protein and 10 573 ± 1099 µmol/min/g protein, respectively. 
The LDH activities of the different dog breeds had a range of 835 to 2514 µmol/min/g protein and 
891 to 3038 µmol/min/g protein for the TB and VL, respectively. In the TB, the Pomeranian appears 
to have the highest activity followed by the Chihuahua (2296 µmol/min/g protein) and Chow Chow 
(2289 µmol/min/g protein), while the German pointer seems the lowest LDH activity followed by the 
fox terrier (1098 ± 278 µmol/min/g protein) and miniature pinscher (1119 ± 115 µmol/min/g protein). 
In the VL, the German shepherd had the highest activity (3038 µmol/min/g protein) followed by the 
Yorkshire terrier (2469 µmol/min/g protein) and the greyhound (2157 µmol/min/g protein). The 
breeds with the lowest LDH activity were the German pointer (891 µmol/min/g protein), Labrador 
(1095 ± 442 µmol/min/g protein) and miniature pinscher (1101 ± 966 µmol/min/g protein). The 
German pointer and miniature pinscher had consistently low LDH activities.   
The activity range of CK was 4531 to 8134 µmol/min/g protein (TB) and 4972 to 12 518 µmol/min/g 
protein (VL). In the TB, the breeds with the highest activity were the Yorkshire terrier (8134 
µmol/min/g protein), dachshund (6684 ± 487 µmol/min/g protein) and Chihuahua (6553 µmol/min/g 
protein). The lowest CK activity belonged to the German pointer (4531 µmol/min/g protein), Chow 
Chow (4817 µmol/min/g protein) and German shepherd (5021 µmol/min/g protein). Interestingly, the 
German shepherd had the highest activity in the VL of 12 518 µmol/min/g protein, and was the fastest 
CK activity. This was followed by the Yorkshire terrier (7184 µmol/min/g protein), Jack Russell 
(6977 ± 1518 µmol/min/g protein) and Chihuahua (6976 µmol/min/g protein). The breeds with the 
lowest activities were the German pointer (4972 µmol/min/g protein), miniature pinscher (5151 ± 
1618 µmol/min/g protein) and fox terrier (5215 ± 869 µmol/min/g protein). The Yorkshire terrier and 
Chihuahua had consistently higher CK activities, while the German pointer had consistently lower 
CK activity. 
The puppies had lower LDH activity than their corresponding adults in the TB and VL. The 
Chihuahua (TB: 2390 µmol/min/g protein; VL: 1569 µmol/min/g protein) had the highest activity, 
followed by the German shepherd (TB: 1096 µmol/min/g protein; VL: 1314 µmol/min/g protein) and 
boerboel (TB: 1375 µmol/min/g protein; VL: 896 µmol/min/g protein). The CK activity of the 
puppies were higher than their corresponding adults in both muscle groups, with the TB having a 
higher activity than the VL. The Chihuahua (TB: 8706 µmol/min/g protein; VL: 5736 µmol/min/g 
protein), German shepherd (TB: 7712 µmol/min/g protein; VL: 6896 µmol/min/g protein) and 
boerboel (TB: 6999 µmol/min/g protein; VL: 5889 µmol/min/g protein). 
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4.4. Discussion  
4.4.1. Oxidative capacity  
CS and 3-HAD act as markers of oxidative capacity with a higher activity indicating a higher flux 
through the respective pathway. The average activity in the TB and VL was very similar to one 
another, with no significant difference between the muscle groups. The range of recreationally active 
and endurance human athletes were included in the figures for comparative purposes. This 
unpublished data was collected in the same laboratory and used as reference guide. Endurance athletes 
Figure 6. (A) CS, (B), 3-HAD, (C) LDH and (C) CK enzyme activities in the Triceps brachii (TB) and Vastus lateralis 
(VL) of each breed contained in this study. Breeds are further grouped into their respective FCI breed group. The 
puppies (below the age of one) are displayed separately. Bars represent either mean or mean ± SD. Black bars 
represent TB, grey bars represent VL. The circles and shaded grey area represents the range of human enzyme 
activities from previous studies.  
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have nearly two times the CS and 3HAD activity of recreationally active humans, and conforms to 
published literature (Schiaffino and Reggiani, 2011). This indicates a higher oxidative capacity as 
there is an increased rate through the Kreb’s cycle and β-oxidation, resulting in the muscle oxidising 
fat and carbohydrate as fuel in an efficient manner. The average CS activity across the dog breeds 
were similar to the endurance athletes, while the 3HAD activity was closer to that of the recreationally 
active humans. In comparison to wild animals, the dog has higher CS and 3HAD activity than the 
lion and caracal (Kohn et al., 2011), but lower activity than antelope species (Kohn, 2014). This 
finding indicates that dogs, overall, have a high oxidative capacity comparable to human endurance 
athletes, but not as high as antelope (such as the blesbok and springbok).  
Across the different breeds, a wide range in CS and 3HAD activities exist. As mentioned in Chapter 
3, it is important to note that there were many breeds with a sample size of one (greyhound, 
Chihuahua, German pointer, Pomeranian, Chow Chow, Yorkshire terrier, Dobermann, boerboel and 
German shepherd) and therefore references to the metabolic results of these breeds are more 
indicative of a case study. The Dobermann, German shepherd, greyhound, Scottish terrier and 
dachshund had the highest CS and 3HAD activities, on average, for the TB and VL. This would 
indicate that these breeds have a higher oxidative capacity and are able to more efficiently utilise the 
Kreb’s cycle and β-oxidation to produce energy. For the German shepherd, Scottish terrier and 
dachsund, the higher oxidative capacity does match the function of these breeds (FCI, 2019). 
However, the Dobermann and greyhound are not considered endurance dogs but rather powerful and 
fast, respectively, thus a surprising find. The German pointer, Chow Chow and boerboel had overall 
low CS and 3HAD activities. This would indicate that these breeds have lower oxidative capacity that 
is closer to a recreationally active human. The boerboel is a powerful, muscular dog that would be 
expected to have a lower oxidative capacity (FCI, 2019). In contrast, the German pointer is considered 
a high endurance Gundog and would be expected to have a higher oxidative capacity as it also had 
one of the highest proportions of type I fibres in their muscles. In contrast, the results for CS and 
3HAD were some of the lowest activities. The oxidative capacity of the Chow Chow matched the 
low proportion of type I fibres observed in Figure 3.   
 
4.4.2. Glycolytic capacity  
CK and LDH activity acts as a marker of the anaerobic capacity of the muscle, which is the ability to 
produce ATP rapidly without oxygen. The average LDH activity of the dog was three times higher 
than the endurance trained human, while the average CK activity was similar to recreationally active 
humans. In comparison to antelope species, the dog has a lower LDH activity and a similar CK 
activity (Kohn, 2014), but the felids (lion and caracal), have much higher LDH and CK activities 
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(Kohn et al., 2011). This would indicate that the dog has an increased ability to convert pyruvate to 
lactate under anaerobic conditions compared to endurance athletes, but a lower ability than antelope 
or felid species. This high glycolytic capacity is quite surprising considering the highly oxidative 
capacity and high proportions of type I and IIA fibres described in the previous chapter. However, 
the muscle fibre type does not necessarily define the oxidative or glycolytic capacity of the skeletal 
muscle, with other factors such as exercise training playing a role or merely genetics (Kohn et al., 
2007a). The training and health status of the dogs included in this study were unknown at the time of 
euthanasia and could have potentially affected the results.  
The different breeds had a variety of CK and LDH activities. Notably, the CK activity of the German 
shepherd in the VL was double the activity in the TB and almost double the average activity of the 
samples. The LDH activity in the VL was also double the activity of the TB. The explanation is not 
known and needs further investigation. Alternatively, this could indicate that German shepherds have 
a very high glycolytic capacity, which would link to the characteristics of this breed. It is considered 
a “high achievement working dog” with good endurance, speed and power (FCI, 2019). Other breeds 
with overall high CK and LDH activities include the greyhound, Chihuahua and Yorkshire terrier. 
This high glycolytic capacity is aligned with the bred for speed characteristic of the greyhound. The 
Yorkshire terrier and Chihuahua are very small dogs which are energetic, but have limited endurance 
(FCI, 2019), and may account for the higher glycolytic capacity in these breeds.  
The breeds with generally lower CK and LDH activities were the German pointer, fox terrier and 
miniature pinscher. Interestingly, the German pointer had overall low oxidative and glycolytic 
capacity. This low glycolytic ability does align with the supposedly high endurance capabilities of 
this breed (FCI, 2019) as well as the low proportions of type IIX and IIA fibres found in this study. 
The original function of the Fox Terrier and Miniature Pinscher was to hunt vermin so they are not 
necessarily powerful dogs and would not need to produce rapid energy through glycolysis.  
 
4.4.3. Muscle metabolism and T2D risk  
Previous studies have shown that, along with fibre type composition being a potential risk factor, the 
metabolism of the muscle may be a risk factor for T2D (Oberbach et al., 2006, Simoneau and Kelley, 
1997). These studies showed that human patients with T2D had a higher ratio of glycolytic to 
oxidative enzyme capacity compared to healthy controls. From the results of this study, it is clear that 
dogs have an inherently high oxidative capacity. Certain breeds (the Dobermann, German shepherd, 
greyhound, Scottish terrier and dachshund) had a greater capacity than other breeds. According to 
Hoenig (2014), the German shepherd is believed to have a lower risk of diabetes, which potentially 
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could be related to its high oxidative capacity because it did not have a particularly high proportion 
of type I fibres.  The risk profile of the other breeds in relation to T2D is unfortunately unknown.  
The German pointer, Chow Chow and boerboel had the lowest oxidative capacity of the various 
breeds. Interestingly, the German pointer had very high proportions of type I fibres, but some of the 
lowest oxidative capacity. However, this breed also had low glycolytic enzyme activity, which may 
balance the ratio of glycolytic to oxidative capacity. The Chow Chow falls under the Spits and 
Primitive Group, which have several breeds at high risk for diabetes (Samoyed, Swedish elkhund and 
lapphund) (FCI, 2019, Hoenig, 2014). Although the risk of the Chow Chow is not known, it does 
seem to have a low oxidative capacity and falls into a group with high risk breeds. The fox terrier is 
believed to have a high risk for diabetes. In this study, it had an average oxidative capacity and a 
higher proportion of type IIA fibres. The metabolism and fibre type of the fox terrier does not seem 
to align with its risk for diabetes. Although exercise is the preferred prescribed preventative measure 
to reduce the risk of acquiring insulin resistance and diabetes in humans, the dogs appear to all have 
a genetically moderate to high oxidative capacity. Thus, overall, it is difficult to establish whether the 
oxidative capacity associates with the risk for diabetes in dogs and requires data from diabetic dogs. 
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CHAPTER FIVE 
5. CONCLUSION 
 
Diabetes is becoming an increasing concern in the human population, with an estimated 422 million 
people living with the disease worldwide (WHO, 2016a). A similar pattern, although with a lower 
prevalence, has been observed in the domestic animal populations, primarily in cats and dogs (Fall et 
al., 2007, McCann et al., 2007). These species are believed to be excellent models to study obesity 
and diabetes in humans, since they share the same environment as humans and develop the disease 
spontaneously (Osto and Lutz, 2015). Interestingly, different dog breeds have been shown to be at a 
higher or lower risk for developing T2D (Hoenig, 2014). It appears that Samoyeds, Swedish elkhound 
and lapphund, fox terriers, Australian terriers, miniature and standard Schnauzers, pugs and poodles 
are at a higher risk, while American pitbull terriers, cocker spaniels, collies, golden retrievers, German 
shepherds and boxers are at lower risk of developing diabetes. With over 300 breeds recognised by 
the FCI and countless other breeds not recognised, the susceptibility of many breeds are unknown.  
Due to the important role of skeletal muscle in the regulation of glucose in the body, it has been 
proposed that the re-programming of type II to type I muscle fibres may be a potential therapeutic 
avenue for the treatment of obesity and T2D (Duan et al., 2017). Therefore, this study aimed to 
characterise the skeletal muscle fibre composition and metabolism of different breeds of domestic 
dogs and to relate the fibre type composition with breeds that are reported to have a higher or lower 
risk of diabetes.  
Type IIA fibres were shown to be the most prevalent fibre type in the breeds analysed, followed by 
type I and then type IIX. However, there was some variability across the different breeds, which may 
be attributed to their function and lifestyle. Breeds, such as the German pointer, dachshund, Labrador 
and miniature pinscher had much higher proportions of type I fibres compared to the greyhound, 
Pomeranian and boerboel. Additionally, the dogs analysed in this study seemed to have a higher 
oxidative capacity than glycolytic capacity, which links to their higher proportions of type I and IIA 
fibres, conforming to previous studies (Acevedo and Rivero, 2006, Snow et al., 1982, Strbenc et al., 
2004, Toniolo et al., 2007). Breeds with a higher oxidative capacity includes the Dobermann, German 
shepherd, greyhound, Scottish terrier and dachshund. Notably, the specific breeds with a higher 
proportion of type I fibres do not necessarily have the highest oxidative capacity. Muscle fibre type 
does not solely dictate the metabolic properties of the muscle (Kohn et al., 2007a). In the study by 
Kohn et al (2007), Xhosa runners had a higher LDH activity in their type I and IIA fibres (LDH is 
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generally higher in type IIA) compared to their Caucasian counterparts. This could highlight the effect 
that training and lifestyle have on the metabolism of the muscle. Therefore, factors such as function 
and lifestyle of dogs may account for their high oxidative capacity, and not solely fibre type. Of 
course, genetics of the different breeds should not be ruled out, but would require a more in depth 
approach of analyses.  
The fibre CSAs of the dogs were similar to that found in a previous study (Acevedo and Rivero, 
2006). Notably, the fibres were markedly smaller than humans, but similar to lion and caracal fibre 
CSA (Kohn et al., 2011). There was a slight correlation between the weight of the dogs and their 
CSAs, with heavier dogs having a greater CSA. It would have been better to correlate muscle mass 
with CSA, as body weight itself includes too many factors (such as fat, organ size, etc) that can skew 
the results. The fibre CSA does not solely determine the power of the muscle, with the number of 
fibres recruited, fibre proportions and ATP supply playing a role (Kohn et al., 2011). However, the 
present study did not investigate power production in the skeletal muscle. Notably,  oxidative fibres 
tended to be smaller than fibres that are more glycolytic, conforming to what was found in the present 
study (Kohn, 2014).   
Unfortunately this study did not contain many breeds that have been classified as having a high or 
low risk of diabetes. The fox terrier (high risk) and German shepherd (low risk) were the only 
classified breeds in the current cohort. The fox terrier was the only dog that had a low proportion of 
type I fibres in the VL and overall, had an average oxidative and low glycolytic capacity. This does 
not conclusively align with the hypothesis proposed by Duan et al. (2017). The German shepherd, on 
the other hand, had a higher proportion of type I and IIA fibres with a high oxidative capacity, which 
potentially aligns with the hypothesis. No definitive conclusions can be drawn from the results 
although, theoretically, fibre type composition could potentially be a factor playing a role in the 
predisposition to diabetes mellitus in dogs. Due to the apparent genetically moderate to high oxidative 
capacity of the dog breeds, it is difficult to establish the association between oxidative capacity and 
the risk of diabetes in each breed.  
In summary, this study was able to characterise the skeletal muscle of 16 breeds (including mixed 
breed) of the domestic dog. The strength of this study is that, for the first time, the muscle fibre type 
and metabolism of a large cohort of dog breeds were studied, providing for a solid foundation for 
future research on the health of these animals.  
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 Limitations and Future directions 
There were a few limitations to the study. First, muscle sampling was opportunistic – thus, the breed, 
sex and age of the samples could not be controlled for or anticipated. This resulted in many of the 
breeds having only one or two study animals (and therefore more indicative of a case study) with 
males and females being grouped together. Small sample sizes are not uncommon in this type of 
research (Acevedo and Rivero, 2006, Strbenc et al., 2004) with the novelty of this study being the 
diversity of breeds investigated. A second limitation was that the clinical reasons for euthanasia of 
the animals were not disclosed to the researcher. Many of the animals were older than 10 years, and 
as a result, “old age” was often recorded as the reason for euthanasia. This may have implications on 
the results, specifically the metabolism of the muscle and muscle fibre size. The results of this study 
are cross sectional in nature and include no known diabetic animals, therefore, it is difficult to draw 
definitive conclusions in relation to diabetes, fibre type and metabolism.  
The present study has formed a foundation for future studies on the role of skeletal muscle fibre type 
composition and metabolism in dog diabetes. Going forward, skeletal muscle composition should be 
investigated in a population of diabetic animals and healthy controls of preferably the same age. 
Additionally, an intervention study to evaluate fibre type and metabolism by inducing insulin 
resistance and T2D in the dog would be better suited to prove or disprove the hypothesis that a 
predominance in type I fibres decreases the risk of acquiring T2D. Future studies should aim to 
include a greater sample size of each breed, so that statistical analyses can be conducted between the 
breeds. Finally, blood glucose regulation, mitochondrial function, insulin receptor integrity (e.g. IRS-
1) and GLUT4 content should be investigated, because this will provide a clearer picture of oxidative 
capacity and insulin sensitivity, respectively, of the skeletal muscle. Due to the inherently high 
oxidative nature of the dog, it would also be beneficial to investigate the oxidative and glycolytic 
enzyme activity in each fibre type through single fibre techniques.  
 
 
 
 
 
 
 
 54 
APPENDIX A 
IMMUNOHISTOCHEMISTRY PROTOCOL 
Reagents and antibodies 
1. Acetone  
2. Phosphate buffered Saline (PBS) 0.15M pH 7.4. In 1L PBS: 8g NaCl (0.14M), 1.26g Na2HPO4 (8.8mM), 
0.2g KCl (2.7mM), 0.2g KH2PO4 (1.5mM), made up to 1L with distilled H2O.   
3. 5% Donkey serum made up in PBS.  
4. Primary Antibodies: Monoclonal mouse BA-D5 IgG2b against MHC I, Monoclonal mouse SC-71 IgG1 
against MHC IIA (lightly binds IIX in canine muscle). Antibodies purchased from Developmental Studies 
Hybridoma Bank (Iowa, USA) 
Secondary antibodies: Polyclonal AMCA goat anti-mouse IgG2b (catalogue number: 115-155-207), 
Polyclonal AlexaFlour 488 goat anti-mouse IgG1 (catalogue number: 115-545-205). Antibodies purchased 
from Jackson Immunoresearch Laboratories (Pennsylvania, USA).  
Method  
Slides were removed from -20°C storage and allowed to air dry before being fixed with acetone for 2 minutes. 
Slides where then hydrated in PBS for 2 minutes and allowed to incubate in 5% donkey serum (50 µL per 
section) for 1 hour at room temperature in a humidifying box. Following the blocking step, slides were 
incubated with a 1:50 dilution (in PBS) of BA-D5 and SC-71 primary antibody (50 µL per section) overnight 
at 4°C in a humidifying box. The next day, the slides were dunked and washed twice in PBS for 2 minutes.  
The following steps occurred in the dark. Slides were incubated with a 1:250 dilution (in PBS) of AMCA and 
AlexaFlour secondary antibody (50 µL per section) for 2 hour at room temperature in a humidifying box. After 
the slides were washed twice in PBS for 2 minutes, they were mounted with 30 µL and stored at 4°C until 
visualisation.   
Sections were visualised with a fluorescent microscope (Nikon Eclipse 80i, New York, USA) and photographs 
taken of a selected section at 10x magnification using a digital camera (Canon EOS 650D, Pretoria, South 
Africa). Sections were small and all fit into the 10x magnification field of view. The number of each fibre type 
was counted for a selected section and expressed as a percentage of the total fibres. An average of 700 fibres 
were counted and typed per section. The cross sectional area (CSA) of a maximum of 50 fibres were 
determined for each fibre type per section using the computer programme ImageJ (version 1.50e, Maryland, 
USA). The image was broken up into quintiles (five areas) and the CSA of 10 fibres of each fibre type in each 
section was determined and averaged, this was to ensure that the entire muscle section was represented.  
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APPENDIX B 
HOMOGENISING BUFFER 
Stock solutions: 
A. KH2PO4  0.1 M Mw 136.1 
 0.6804 g / 50 ml dH2O  
B. K2HPO4 0.1 M Mw 174.2 
 0.871 g / 50 ml d H2O 
Add 30 ml of buffer B to a small beaker and place pH probe into that solution. Use buffer A and adjust 
buffer to pH 7.30. This buffer can be stored at –20 °C.  
 
ENZYME ASSAY PROTOCOL AND DATA 
All the enzyme assays described below use the principle of fluorometry.  The measured fluorescence comes 
from reduced forms of NAD and NADP. The reaction can either in itself cause the increase or decrease (e.g. 
NADH + H+), or be coupled to such a reaction. During analysis, the fluorescence is measured at known time 
intervals and difference per minute is calculated. Knowing the protein concentration, and its dilution, the 
enzyme activity, expressed as µmol/min/g protein, is calculated. The fluorescence is measured at a sensitivity 
of 100.  
NADH and NADPH Standard curve   
Na2CO3 :  0.08 M; Mw 105.99; 0.848 g 
NaHCO3 : 0.02 M; Mw 84.01; 0.168 g 
     Make up to 100 ml dH20. This buffer is used to make up NADH and NADPH.  
 
NADH:   ±5 mM; Mw 709.3  
               36 mg dissolve in 10 ml buffer 
   Heat NADH solution for 10 min in a water bath at 60°C to destroy NAD+ 
 
NADPH: ± 5 mM; Mw 833.4  
                25 mg dissolve in 6 ml buffer 
    Heat NADPH solution for 10 min in a water bath at 60°C to destroy NADP+ 
 
Generating NADH or NADPH standard curve:  
1. Use black plates. Make sure the fluorometer is switched on for at least 20 minutes. Set the excitation 
wavelength to 340/11 nm and the emission wavelength to 460/40 nm.   
2. Read the background fluorescence of each well.   
3. Dilute the original NADH standard 11 times (1:10) with dH2O. Dilute the original NADPH standard 
3 times (1:2) with dH2O.   
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4. Pipette 0, 2, 4, 6, 8, 10 µL volumes in duplicate into each well.   
5. Add 250 µl Tris or Imidazole buffer to each well and read. The final concentration of the buffer is 
dependent on the concentration required in the respective assay.   
6. Subtract each background value from each NADH or NADPH read.   
7. Subtract the blank value from the rest of the measurements.   
8. Draw a graph with the fluorescence values on the Y-axis and NADH or NADPH concentration (μM) 
on the X-axis.  
9. Determine the slope, expressed as fluorescent units / μM 
 
Citrate Synthase  
Reaction: 
                                                                                     
Acetyl-CoA                                         CS 
MDH    
L-malate                          oxaloacetate                               citrate 
 
               NAD+          NADH + H+ 
 
Stock solutions: 
 
Tris-buffer 1 M, pH 8.0  ; Mw  121.1  (Sigma T-1503) 
  12.11g / 100 ml dH2O; adjust pH 
 
EDTA    0.1 M   ; Mw  372.2 (Sigma E-5134) 
  3.722 g / 100 ml dH2O 
 
NAD+  0.1 M;   Mw  663.4 (Roche 127 965) 
  69 mg / 1 ml dH2O 
  Freeze at -80˚C in aliquots 
 
L-malate 0.1 M;   Mw 156.1 (Sigma M-1125) 
  78 mg / 5 ml dH2O 
  Freeze at -80˚C in aliquots 
 
Acetyl-CoA 3 mM;   Mw 809.6 (Sigma A-2056)              
  Freeze at -80˚C in aliquots 
Dissolve 5 mg in 2 ml dH2O, exact amount depending on analysis of each batch as indicated on vial. This 
will result in the [final] in 260 µl to be 60 µM. 
 
Malate dehydrogenase (MDH) 5 mg/ml (Roche 127 256) 
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Reagent solution 
  25 ml: 50 ml: 120ml: [Final] 
Tris buffer 1 M, pH 8.0 2.5 ml 5.00 ml 12 ml 0.1 M 
EDTA 0.1 M 625 µl 1.25 ml 3.0 ml 2.5 mM 
NAD+ 0.1 M 125 µl 250 µl 600 µl 0.5 mM 
L-malate 0.1 M 250 µl 500 µl 1.2 ml 1.0 mM 
MDH 5 mg/ml 40 µl   80 µl 192 ml 8 µg/ml 
Fill up with dH2O to desired volume. Check pH 8.0 
Add 250 µL of reagent solution, 10 µL of dog homogenate, 5 µL Acetyl-CoA to each well in duplicate. The 
assay runs for 3 minutes, use the maximum slope to determine Fl/min. Use NADH standard curve, as 
previously described, with 0.1M Tris.   
 
3-Hydroxyacetyl CoA Dehydrogenase (3-HAD) 
 
Reaction: 
                                    3-HAD 
 Acetoacetyl-CoA                                           3-hydroxyacetyl-CoA 
 
                                      NADH + H+             NAD+ 
 
Stock solutions: 
 
Imidazole buffer    1 M, pH 7.0;  Mw  68.1 (Sigma I-0125) 
                    6.8g / 100 ml dH2O; adjust pH 
 
EDTA        0.1 M   ; Mw  372.2 (Sigma E-5134) 
      3.722 g / 100 ml dH2O 
  
NADH                    0.1 M;   Mw  709.4 (Roche 107 735) 
                    17.7 mg / 250 µl dH2O 
                    Freeze at -80˚C wrapped in tin foil for not longer than 2 months. 
 
Acetoacetyl-CoA   1 mM;   Mw 971.6 (Sigma A-1625)  
Dissolve 5 mg in approximately 1 ml dH2O (4.9 mM). Dilute this to 1 mM aliquots and freeze at -80˚C for 
later use. This will result in the [final] in 260 µl to be 20 µM.   
Reagent solution 
  25 ml: 50 ml: 120ml: [Final] 
Imidazole buffer 1 M 1.25 ml 2.5 ml 6 ml 50 mM 
EDTA 0.1 M 1 ml 2 ml 4.8 ml   4 mM 
NADH 0.1 M 7.5 µl 15 µl 36 µl 30 µM 
Fill up with dH2O to desired volume. Check pH 7.0 
Add 250 µL of reagent solution, 5 µL of dog homogenate, 5 µL Acetoacetyl-CoA to each well in duplicate. The 
assay runs for 5 minutes, use the maximum slope to determine Fl/min. Use NADH standard curve with 50 mM 
Imidazole.   
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Lactate Dehydrogenase (LDH) 
 
Reaction:                       LDH 
  Pyruvate                                                Lactate 
 
       NADH + H+        NAD+ 
 
Stock solutions: 
 
Tris-buffer 1 M, pH 8.0  ; Mw  121.1  (Sigma T-1503) 
  12.11g / 100 ml dH2O; adjust pH 
 
EDTA    0.1 M   ; Mw  372.2 (Sigma E-5134) 
  3.722 g / 100 ml dH2O 
 
NADH               0.1 M;   Mw  709.4 (Roche 107 735) 
               17.7 mg / 250 µl dH2O 
               Freeze at -80˚C wrapped in tin foil for not longer than 2 months. 
 
Pyruvate             1.0 M;   Mw  110.0 (Roche 128 147) 
               220 mg / 2 ml dH2O 
               Freeze at -80˚C in aliquots. [Final] will be 2 mM in 260 µl 
 
Reagent solution 
  25 ml: 50 ml: 120ml: [Final] 
Tris buffer 1.0 M 1.25 ml 2.5 ml 6 ml 50 mM 
EDTA 0.1 M 1 ml 2 ml 4.8 ml 4 mM 
Pyruvate 1.0 M 50 µl 100 µl 240 µl 2mM 
NADH 0.1 M 15 µl 30 µl 72 µl 60 µM 
Fill up with dH2O to desired volume. Check pH 7.6 
Add 250 µL of reagent solution, 2 µL of dog homogenate to each well in duplicate. The assay runs for 2 
minutes, use the maximum slope to determine Fl/min. Use NADH standard curve with 50 mM Tris.  
 
 
Creatine Kinase (CK) 
 
Reaction: 
                                                                  G-6-P-DH 
Creatine-P  Glucose-6-P                                             Gluconate-6-P 
          ADP   
CK       HK                              NADP+      NADPH + H+ 
 
 
Creatine         ATP        Glucose 
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Stock solutions: 
 
Imidazole-EDTA-Mg-acetate buffer EDTA 0.149 g; Imidazole 1.361 g; Magnesium acetate 0.429 
g 
 Dissolve in 150 ml dH2O and pH to 6.7 with HCl. 
 
Glucose 0.5 M;   Mw 916.4 (Sigma G-7528) 
915 mg/ 2 ml dH2O 
 
ADP 0.5 M;   Mw 427.2 (Sigma A-2754) 
213 mg/ 1 ml dH2O 
 
AMP 0.5 M;   Mw 427.2 (Sigma A-2754) 
213 mg/ 1 ml dH2O 
 
Creatine phosphate 0.5 M;   Mw 327.2 (Roche 621722) 
327 mg/ 2 ml dH2O 
 
Diadenosine Pentaphosphate (DAPP) 10 mg/ml Mw 916.4 (Sigma D4022) 
 
NADP+ 0.1 M;   Mw 787.2 (Roche 128058) 
79 mg/ 1 ml dH2O 
 
N-Acetylcysteine (NAc) 0.5 M Mw 163.2 (Sigma A-7250) 
82 mg/ 1 ml dH2O 
 
Hexokinase 1500 U/ml (Roche 1426362) 
 
Glucose-6-phosphate dehydrogenase 1750 U/ml (Roche 127655) 
 
Reagent solution 
  25 ml: 50 ml: 120ml: [Final] 
Imidazole-EDTA-Mg buffer pH 6.7 7.5 ml 15 ml 90 ml  
Glucose 0.5 M 80 µl 160 µl 960 µl 4 mM 
ADP 0.5 M 40 µl 80 µl 480 µl 2 mM 
AMP 0.5 M 100 µl 200µl 1.2 ml 5 mM 
Creatine phosphate 0.5 M 600 µl 1.2 ml 7.2 ml 30 mM 
DAPP 11 mM 9.15 µl 18.3 µl 110 µl 10 µM 
NADP+ 0.1 M 80 µl 160 µl 960 µl 800 µM 
NAc 0.5 M 400 µl 800 µl 4.8 ml 20 mM 
QS to desired volume using dH2O. This reagent can be 
frozen at -20 ˚C. Before use, add the following: 
 
 
 
Hexokinase 1500 U/ml 16.7 µl 33.3 µl 200 µl 2.5 U/ml 
Glucose-6-phosphate DH 1750 U/ml 8.6 µl 17.1 µl 103 µl 1.5 U/ml 
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Fill up with dH2O to desired volume. Check pH 6.7 
Add 250 µL of reagent solution, 0.5 µL of dog homogenate to each well in duplicate. Alternatively samples 
can be diluted to 1:800. The assay runs for 6 minutes, use the maximum slope to determine Fl/min. Use NADPH 
standard curve with 50 mM Imidazole.  
 
 
Table 2. Mean CS, 3-HAD, LDH and CK activity for 38 dog samples and comparative human data 
 Dog Enzyme Activity 
(µmol/min/g protein) 
Human Enzyme Activity 
(µmol/min/g protein) 
 Triceps brachii 
(n=38) 
Vastus lateralis 
(n=38) 
Recreationally 
active (n=6) 
Endurance 
athlete (n=6) 
CS 61 ± 16 49 ± 13          27 ± 7 57 ± 17 
3-HAD 53 ± 14 46 ± 16 43 ± 12 90 ± 15 
LDH       1550 ± 592       1478 ± 658 331 ± 165 557 ± 167 
CK 6115 ± 1081 6279 ± 1529 5897 ± 1003    10573 ± 1099 
Data expressed as mean ± SD 
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